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ABSTRACT 
Amperometric sensors for Tenofovir, a model nucleotide/ nucleoside reverse transcriptase 
inhibitor ARV drug, were studied based on the principle of ion-transfer electrochemistry at 
the membrane-stabilized oil/ water interface (O||W) in a four-electrode cell set-up. Solutions 
of the hydrophobic salts tetradodecylammonium tetrakis(4-chlorophenyl) borate (ETH500), 
ethyl violet tetraphenylborate (EthVTPB), tetrabutylammonium tetraphenylborate 
(TBATPB), tetraphenylphosphnium tetraphenylborate (TPphTPB) and three ionic liquids 
(Methyltrioctylammonium bis(trifluoromethyl sulfonyl)imide (IL1), 1-butyl-3-
methylimdazolium bis(trifluoromethyl sulfonyl)imide (IL3) and 1-propyl-3- 
methylimdazolium bis(trifluoromethylsulfonyl)imide (IL4)) in nitrobenzene (NB), 1,2-
dichloroethane (DCE), and 2-nitrophenyloctyl ether (NPOE) were each tested as O-phases. 
The cyclic voltammograms of the resulting O||W interfaces in aq. Li2SO4 or aq. MgSO4 were 
compared with respect to noise, potential window, and other parameters. The three ILs were 
also tested as self-sufficient salts without a solvent medium. In the end, the ETH500/ DCE 
salt/ solvent pair was found to yield the best behaved polarizable O||W interface in aq. 
MgSO4. The analytical characteristics of the resulting sensors to tenofovir without 
(Ag|ETH500/DCE||) and with the dibenzo-18-crown-6 (Ag|ETH5000/DB18C6/DCE|| in the 
O-phase were studied with respect to the two pairs of peaks in the CV, namely the WO ion 
transfer peak and the reverse OW peak. Both sensors exhibited operational stability of 90 
min. After consideration of reasonable S/N ratio and sample throughput rates, the scan rate of 
25 mV/ s was used in subsequent signal interrogation with CV. The final potential windows 
were 0.95 V wide for Ag|ETH500 (10 mM)/ DCE|| in aq. MgSO4 (50 mM) and 0.70 V wide 
for Ag|ETH500 (10 mM)/ DB18C6 (50 mM)/ DCE|| in aq. MgSO4 (50 mM). From plots of 
peak currents versus square of scan rate, tenofovir diffusion coefficients of about 2.48 × 10-11 
cm2/ s were estimated, which indicated diffusion through the supporting membrane as the rate 
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limiting process. Based on WO ion transfer peaks, the first one exhibited a detection limit 
of about 5 µM, a linear range of 15 – 100 µM, and sensitivity of 7.09 nA µM-1 towards 
tenofovir, whereas for the second one these were respectively 3 µM, 6.32 nA µM-1, and 9 – 
100 µM. In this way, a four-electrode amperometric detection of ion transfer process at liquid 
| liquid interface, both under simple and ionophore-facilitated mode, has been demonstrated 
as promising for analysis of tenofovir as a representative of the nucleotide/ nucleoside reverse 
transcriptase inhibitor ARV drugs.  
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CHAPTER I: INTRODUCTION 
Ionic charge transfer reactions at a liquid/ liquid (L/L) interface are one of the most 
important physicochemical processes. The liquid/liquid interface is actually made up of two 
immiscible electrolyte solutions. For example, organic phase which is hydrophobic and 
aqueous phase is hydrophilic [1–5]. These charge-transfer reactions which can occur across 
such an interface can be classified into two main classes: 
Simple Ion-transfer (IT) reactions: 
Are the easiest to investigate, when an ion has a relatively low Gibbs energy of transfer and 
its value is within the potential window of the experimental system, the transfer can occur if 
the liquid/liquid interface is polarized. The valence state of the ion does not change, so that 
only the solvation is varied while the transfer is occurring, there have been several reports on 
this subject, ranging from simple inorganic and organic ions to drugs and biomolecules [2–
4,6]. Most IT reactions are fast and can be considered as reversible [2]. 
Facilitated ion-transfer (FIT) reaction:  
It is occurs when an ion has higher (or lower) Gibbs energy of transfer at a liquid/liquid 
interface, the transfer  normally appears outside the potential window or very near the 
positive or negative end of the potential window, so that it is difficult to study the simple IT 
reaction directly. In order to solve such a problem, a ligand (ionophore), which can complex 
with the ion, can be chosen to be put into either phase to lower the Gibbs energy of transfer. 
Such a process is called a FIT reaction [2,4,5] 
Various ionophores, such as crown ethers, antibiotics and calixarenes have been employed to 
facilitate ion transfer reaction, but in this study among the crown ethers dibenzo-18-crown-6 
will play essential role. Fig 1 shows the structure of DB18C6.  
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Fig 1: structure of dibenzo-18-crown-6 (DB18C6) 
Nucleoside reverse transcriptase inhibitors (NRTIs) were the first anti-retroviral (ARV) drugs 
to be approved for the treatment of human immunodeficiency virus (HIV), with zidovudine 
(AZT) since 1987; and, these drugs still continue to be the back bone of the current treatment 
guideline known as highly active antiretroviral therapy (HAART) [7–12]. A HAART 
prescription usually contains two (or three) ARV drugs in a fixed dose combination, one (or 
two) of which is an NRTI and the other being an ARV with a different mechanism of action, 
for instance, a non-nucleoside reverse transcriptase inhibitor (NNRTI), or a protease inhibitor 
(PI), or an integrase inhibitor (INI) [13,14].  
The efficacy of routine treatment of HIV infections with existing HAART drugs and the 
success of newer clinical trials obviously depend on the availability of specific and accurate 
standard analytical methods to reliably detect and quantify these substances and their 
metabolites in-vitro and in-vivo. In this regard, HPLC, GCMS, and UV - visible absorption/ 
fluorescence/ spectroscopy – based protocols remain to be key tools. However, methods 
based on electrochemical sensors could be superior when the priorities to address are (a) the 
increasing demand for quick, economical, portable, and personalized devices; and, (b) 
futuristic medicine based on implanted devices, real-time monitoring, and controlled drug 
release.  
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Of particular interest is the possible application of simple and ionophore-assisted ion-transfer 
electrochemistry (IT) at an electrified interface between two immiscible electrolyte solutions 
(ITIES), to develop such sensors for a selection of approved and new NRTIs (zidovudine, 
didanosine, zalcitabine, stavudine, lamivudine, abacavir and emtricitabine). In contrast with 
traditional solid-state electrode sensors, at which such analyze could undergo irreversible 
electrochemistry causing electrode fouling effects, an IT@ITIES-based sensor would 
generate signals without oxidizing or reducing the analyze. Thus, both the sensor and the 
sample would be re-usable. It also yields data on drug lipophilicity and partition.  
In this MSc thesis work, various membrane-stabilized macro ITIES (water/ nitrobenzene, 
dichloroethane, hydrophobic room temperature ionic liquids, 2-nitrophenyloctyl ether), and 
supporting electrolytes were tested and compared with respect to a set of analytical 
parameters by developing sensors based on simple and DB18C6-facilitated transfer of 
Tenofovir as a model nucleotide/ nucleoside reverse transcriptase inhibitor ARV drug. The 
electrochemical technique used was cyclic voltammetry.  
The objectives of this thesis include: 
(i) Literature review of the electrochemistry of, electrochemical sensors, for nucleoside 
and nucleotide reverse transcriptase inhibitor (NRTI) ARV drugs. 
(ii) Study the analytical performance of simple and facilitated ion transfer based 
electrochemical sensors for Tenofovir as a model NtRTIs/ NRTIs drug. 
Chapter I gives an introduction to liquid/liquid interface technique and (NRTIs / NtRTIs).  
The rationale and motivation of this project are also given as well as, the objectives that need 
to be met. 
Chapter II gives the literature review which review the classification of NRTIs and NtRTIs 
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and there structure, and the type of sensors more over the electroanayltical analysis. 
Chapter III which retrace the essential theory of electrochemistry at the ITIES and 
measurements of part ion coefficient also the diffusion coefficient the following topics are 
covered in the present study. 
Chapter IV gives experimental, an account on the specific chemical used in the analysis, 
before explaining in detail solutions preparation and electrochemical analysis. 
Chapter V shows cyclic voltammetry using four electrode cells used to explore the 
partition and diffusion coefficients of tenofovir. 
Chapter VI concludes this thesis by summarizing the main points highlights the novelty of 
the research and, offers conclusions and recommendations as well as future work. 
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CHAPTER II: LITERATURE REVIEW 
Until now after the human immunodeficiency virus (HIV) was discovered as the tentative a 
etiological agent of acquired immune deficiency syndrome (AIDS), exactly 25 anti-HIV 
compounds have been formally approved for clinical use in the treatment of AIDS. These 
compounds fall into six categories: nucleoside reverse transcriptase inhibitors (NRTIs) 
nucleotide reverse transcriptase inhibitors (NtRTIs), non-nucleoside reverse transcriptase 
inhibitors (NNRTIs), protease inhibitors (PIs), fusion inhibitors (FIs), co-receptor inhibitors 
(CRIs), and integrase inhibitors (INIs) [15]. But the reviews will be in Nucleoside and 
Nucleotide reverse transcriptase inhibitors a) what they are b) general analysis for (NRTIs 
and NtRTIs), c) electrochemical analysis  
Table 1: Approved Structure of the NRTIs and NtRTIs [15] 
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Table 2: Approved anti-HIV (NRTIs and NtRTIs) drugs (adopted from ref. [16]) 
Categories Generic Name Brand name Manufacturer 
NRTIs 
Zidovudine Retroviral GlaxoSmithKline 
Didanosine 
Videx(tablet) 
Bristol-Myers Squibb 
Videx EC (capsule) 
Zalcitabine Hivid Hoffmann-La Roche 
Stavudine Zerit Bristol-Myers Squibb 
Lamivudine Epivir GlaxoSmithKline 
Abacavir Ziagen GlaxoSmithKline 
Emtricitabine Emtriva Gilead Sciences 
 NtRTIs Tenofovir Viread Gilead Sciences 
2.1 Nucleoside/ Nucleotide reverse transcriptase inhibitors  
The reverse transcriptase (RT) enzyme associated with HIV is actually the target of three 
classes of inhibitors: nucleoside RT inhibitors (NRTIs); nucleotide RT inhibitors (NtRTIs); 
and non-nucleoside RT inhibitors (NNRTIs). The NRTIs and NtRTIs interact with the 
catalytic site (that is the substrate-binding site) of the enzyme, whereas the NNRTIs interact 
with an allosteric site located at a short distance (ca. 15Å) from the catalytic site Fig 2. 
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Fig 2:  HIV reverse transcriptase with the binding site for the (NRTIs) and (NtRTIs) and the binding 
site for the (NNRTIs).  According to De Clercq [17]; structure of the enzyme according to Tantillo et 
al. [18] 
2.1.1 Nucleoside reverse transcriptase inhibitors (NRTIs) 
The reverse transcriptase associated with HIV is actually the target for three classes of 
inhibitors: NRTIs, NtRTIs, and NNRTIs. The NRTIs and NtRTIs interact with the catalytic 
site of the enzyme, whereas the NNRTIs interact with an allosteric site located at a short 
distance from catalytic site. They were seven NRTIs in 2010 that have been formally 
approved for the treatment of HIV infections, zidovudine (AZT), didanosine (ddI), 
zalcitabine (ddC), stavudine (d4T), lamivudine (3TC),abacavir (ABC) and emtricitabine 
(FTC) [15,19] (Table1and 2). All the NRTIs could be considered as 2`,3`- dideoxynucleoside 
analogues and act in a similar fashion [16]. In Fig 3 shows example for the mechanism of 
NRTIs. 
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Fig 3: AZT Mechanism of action of Following phosphorylation to its triphosphate form (AZT-TP) 
AZT acts as a competitive inhibitor/alternative substrate with respect to dTTP in the reverse 
transcriptase reaction [20]. But the NRTIs reduced to six, because the Zalcitabine is not any 
more continue [21].  
2.1.2 Nucleotide reverse transcriptase inhibitors (NRTIs) 
NtRTIs should be clearly distinguished from the NRTIs as they are nucleotide analogues, 
which means that they only need two phosphorylation steps to be converted to their active 
form. Also, they contain a phosphonate group that cannot be cleaved by esterase's, which 
would make it more diﬃcult to cleaved oﬀ these compounds, once incorporated at the 3`-
terminal end, compared with their regular nucleotide counterpart. The mode of action of 
Tenofovir is further illustrated in Fig 4 [16]. After phosphorylation of Tenofovir to its 
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diphosphate, the latter acts as an obligate chain terminator in the reverse transcriptase. 
reaction [22]. 
 
Fig 4: Tenofovir Mechanism of action (from ref. [16])  
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2.3 General Analytical Methods for Nucleoside and Nucleotide reverse transcriptase 
inhibitors  
High performance chromatography play role in NRTIs detection with the UV-VIS 
spectroscopy [23]. 
Dadanosine detected by HPLC-UV assay methods 
Table 3: Pharmacokinetic parameters for orally administered didanosine (Adopted from ref. 
[24]) 
NRTIs 
Cmax 
/ ng/mL 
Tmax(h) t1/2(h) 
MRT 
/ h 
AUC 
/ng.h/mL 
CLR 
/mL/min 
UR 
(%) 
Didanosine 1.617± 0.715 0.67±0.19 1.47±0.17 2.12±0.26 2.953±0.851 368±149 17±8 
Keys: AUC = The area under the C versus t curve; AUMC = the area under the first moment 
of the concentration-time curve; C = Concentration; T = Max peak time; t1/2 = Elimination 
half-time; MRT = Mean residence time; UR = Total urinary recovery; CLR =Renal clearance, 
were estimated by standard methods [25]. 
Lamivudine and Zidovudine detected by HPLC-UV methods 
Table 4: Analytical performance of HPLC methods for the NRTIs with Uv-Vis detection at 
260 nm according to Aymard et al [23] 
NRTI 
Range of calibration 
/ ng/ mL 
Retention time 
/ min 
% recovery rate 
(human plasma) 
Lamivudine 20-1000 8.5 80.0±4.2 
Zidovudine 10-500 17.4 77.0±4.1 
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 lamivudine concentrations also fix by liquid chromatography-mass spectrometry and 
intracellular lamivudine-TP concentrations in peripheral blood mononuclear cells by high-
performance liquid chromatography/radioimmunoassay methods [26]. 
Stavudine and Abacavir detected by: 
A reversed-phase high-performance liquid chromatography using silica column to detect the 
stavudine and Abacavir in different wavelength (271 and 230 nm) respectvily, beside that the 
regression coefficient (r2) of all calibration curve was greater than 0.998. The concentration 
range was (10 – 10000 ng/mL). The other detections and values in table (4) [27]. 
Table 5: Analytical performance of a reversed- HPLC methods for the Stavudine and 
Abacavir (Adopted from ref. [27]) 
NRTIs Rerention time (min) Linearity (mean±SD) Accuracy Recovery (%) 
Stavudine 15.7 1.396±0.078 94.8 – 104 ˃ 97.4 
Abacavir 25.1 1.8719±0.03 101 – 90.5 ˃ 96.8 
Tenofovir detection  
Tenofovir also known as (phosphorylmethoxy) propyl-adenine [PMPA] is new anti-HIV drug 
which is a nucleotide reverse transcriptase inhibitor [28,29]. Tenofovir disoproxil fumarate is 
used for oral management to improve abdominal absorption  [30]. The absorption, circulation 
and intracellular activation of the free Tenofovir occur subsequent to hydrolysis of the pro-
drug. Chemically, Tenofovir is a monophosphonate adenosine analogue (as seen in table 1). 
Tenofovir was determined in human plasma due to a recent increase in use. HPLC has been 
used to determine Tenofovir in plasma using HPLC coupled with fluorescence and UV 
detection [31,32]; however, it can not easily detect and quantify tenofovir because of 
interfering peaks. A rapid and conventional LC-MS method was developed and validated by 
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estimating the precision and accuracy for inter- and intraday analysis in the concentration 
range of 0.019-1.567 mg/ml. [33,34]. 
Pharmacokinetic analysis 
Pharmacokinetic parameter for Tenofovir was calculated by noncompartmental methods by 
use of the WinNonlin software package (version 4.1) and the log/linear trapezoidal rule. On 
the basis of the individual plasma concentration-time data, the following pharmacokinetic 
parameters were determined [35]. 
Eventhough, the study’s objective was to investigate if rifampin influences the pharmacokinetics 
of tenofovir, it gave information regarding the possible plasma concentrations of the drug in question. 
The period of study was between 10 to 20 days study showed that bioequivalence could be suggested 
for tenofovir DF combined with rifampin and tenofovir DF given alone and that the combination of 
tenofovir DF with rifampin was generally well born, under the concentration-time curve from 
time zero to 24 h (AUC0-24), the maximum concentration of drug in plasma (Cmax), and the 
minimum concentration of drug in plasma Cmax, and C min were 0.84 to 0.92, 0.78 to 0.90, 
and 0.80 to 0.91 respectively, the data from this study demonstrate that the addition of 
rifampin to tenofovir DF is well tolerated, and the small decrease in plasma tenofovir 
levels during combination treatment suggests that these drugs can be co-administered 
without the need for dose adjust.[35] 
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 Table 6: Pharmacokinetics of tenofovir 
Study day and statistics 
AUC0-24/ 
mg · h/ liter 
Cmax/ 
mg/ liter 
Cmin/ 
 mg/ liter 
Tmax/ 
hc 
t1/2/ 
 h 
Day 10 3.56 ± 0.77  
(3.48)b 
0.36 ± 0.080  
(0.36) 
0.071 ± 0.016 
 (0.069) 
1.0  
(1.0-3.0) 
13.8 ± 4.5 
 (13.2) 
Day 20 3.11 ± 0.57  
(3.06) 
0.30 ± 0.060 
 (0.30) 
0.060 ± 0.011 
 (0.059) 
1.0  
(1.0-2.0) 
11.6 ± 2.8 
 (11.2) 
Geometric mean ratio for 
day 20/day 10 (90% CI) 
0.88  
(0.84-0.92) 
0.84  
(0.78-0.90) 
0.85  
(0.80-0.91) 
  
b Values are arithmetic means ± standard deviations (geometric means), unless indicated 
otherwise. 
c Values are medians (ranges). 
2.3 Electrochemical detection of Nucleoside Reverse Transcriptase Inhibitor 
2.3.1 Electrochemical sensors 
Electrochemical sensors are chemical sensors in which the chemical information is 
transduced into an electrical signal [36] 
2.3.1.1 Principle of electrochemical sensors 
Electrochemistry implies the transfer of charge from an electrode to another phase, which can 
be a solid or a liquid sample. During this process chemical changes take place at the 
electrodes and the charge is conducted through the bulk of the sample phase. Both the 
electrode reactions and/or the charge transport can be modulated chemically and serve as the 
basis of the sensing process [37]. On the basis of electrical signal which is recorded, 
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electrochemistry can be divided into amperometric sensors, potentiometric sensors and 
Conductometric sensors. 
2.3.1.2 Potentiometric sensors 
In potentiometric sensors, the analytical information is obtained by converting the recognition 
process into a potential signal, which is proportional (in a logarithmic manner) to the 
concentration (activity) of species generated or consumed in the recognition event [38]. In 
such device, use of reference electrode is required to provide a constant half-cell potential. 
The change in the potential is related to the concentration of the analyte in a logarithmic 
manner. Thus, the Nernst equation relates the potential difference at the interface to the 
activities of species i in sample phases (s) and the electrode phase (β) and is given by Wang 
et al [37]: 
  
a
a
Z
RT
EE B
i
s
i
i
o ln+=       (1) 
where Eº is the standard electrode potential of the sensor electrode; ai is the activity of the 
ion, R is the universal gas constant; T is the absolute temperature; F is the Faraday constant 
and zi is the valence of the ion. The ion-selective electrode (ISE) for the measurement of 
electrolytes and for obtaining the potential signal is a common potentiometric sensor [37,38]. 
2.3.1.3 Amperometric sensors 
Amperometry is a method of electrochemical analysis in which the signal of interest is a 
current that is linearly dependent upon the concentration of the analyte [38]. Amperometric 
sensors are based on the detection of electro active species involved in the chemical or 
biological recognition process [37].  
 
 
 
 
15 
 
The signal transduction process is obtained by applying the potential to the working electrode 
at a constant value of a reference electrode and monitoring the current as a function of time. 
That applied potential serves as the driving force for the electron transfer reaction of the 
electro active species.  
The resulting current is flection of the rate of the recognition event, and is proportional to the 
concentration of the target analyte, because it is a direct measure of the rate of the electron 
transfer reaction [36].  
In redox reactions at the working electrodes, electrons are moving from the analyte to the 
electrode or to the analyte from the electrode. The direction of flow of electrons can depend 
upon the properties of the analyte as long as it can be controlled by the electric potential 
applied to the working electrode [37]. An amperometric cell consists of two or three 
electrodes, which are working electrode, reference electrode and the counter (or auxiliary). 
2.3.1.4 Conductometric sensors 
Conductometric sensors are based on the measurement of electrolyte conductivity, which 
varies when the cell is exposed to different environments. The sensing effect is based on the 
change in of the number of mobile charge carriers in the electrolyte. If the electrodes are 
prevented from polarizing, the electrolyte shows ohmic behavior. Conductivity measurements 
are generally performed with AC supply [36].  
Conductivity increases with increasing ion concentration; therefore, it can be used for sensor 
applications. However, it is nonspecific for a given ion type. On the other hand, both the 
polarization and the limiting current operation mode must be avoided. Thus, small amplitude 
alternating bias is used for the measurements with frequencies where the capacitive coupling 
is not determining the impedance measurement [36]. 
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Table 7: Electroanaylitcal methods for the determination of NRTI are reported between 1990 
and 2010 as reviewed by Bonzal et al (2011)[15].  
Compound  Electrode/ Platform Technique Linear range LOD Ref. 
Abacavir 
 
 
DPV 0.80-200 µM 0.220 µM 
[39,40] 
SWV 0.80-200 µM 0.118 µM 
CV 0.10 - 10.0 µM 21.1 nM 
DPV 0.10 – 10.0 µM 24.1 nM 
SWV 0.10 – 10.0 µM 26.9 nM 
Didanosine 
CoPc-CPE DPV 2.0 -700.0 µM 0.880 µM 
[41] 
FePc-CPE DPV 1.0-800.0 µM 0.350 µM 
Lamivudine 
 
 
DPV 4.0 -100.0 µM 62.8 nM 
[42,43] 
SWV 4.0-100.0 µM 20.2 nM 
CAdSV 458.5 – 2.3 µM 0.003 nM 
DPV 0.09 – 5.73 µM 0.00094 nM 
Zidovudine 
 
SWV  250 nM 
[44–47] 
SWV 0.500 nM - 1 µM 1 nM 
AgHg//Hg DPV 0.4-1500 µM 0.12 µM 
AgHg DPV 0.6-1500 µM 0.20 µM 
HMDE DPV 0.03-1900 µM 0.007 µM 
 DPV 0.25-1.25 mg/L 0.0025 mg/L 
DPV = differential pulse voltammetry; SWV = square wave voltammetry; CV = cyclic 
voltammetry; CAdSV = Cathodic adsorptive stripping voltammetry; CoPc-CPE = Cobalt (II) 
phthalocyanine carbon paste electrode; FePc-CPE = Iron (II) phthalocyanine carbon paste 
electrode; HMDE = Hanging mercury drop electrode; AgHg/Hg = Silver amalgam electrode 
with polished surface; AgHg = surface modified by mercury meniscus. 
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CHAPTER III: ELECTROCHEMISRY AT THE ITIES: THEORY & 
APPLICATIONS 
A conventional electrochemical set up comprises three electrodes among which we count the 
working electrode, the counter or auxiliary electrode and the reference electrode. But in the 
case of electrochemical experiments at the interface between two immiscible electrolyte 
solutions (ITIES), two counter electrodes and two reference electrodes, one per each phase, 
are usually required in such a way to measure the potential drop and net ionic charge transfer 
current across the interface, and in effect the interface acts as the working electrode. ITIES is 
now regarded as a valuable technique and as such the literature with reference to this type of 
technique is wider growing.[5,48,49]. 
3.1 Electrochemistry at the interface between two immiscible electrolyte solutions 
In the ITIES experiment, voltage is applied between two reference electrodes positioned on 
opposite sides of the interfacial boundary, and the current flows between two counter 
electrodes one in an aqueous phase, the other in an organic phase Fig 5a. The reaction is 
driven by the voltage applied across the liquid interface, and the measured current arises from 
ion transfer (IT) or electron transfer (ET) at the ITIES. An ET reaction at the ITIES can be 
represented as 
)(2)(1Re)(2Re)(1 orgOxaqdorgdaqOx +⇔+                                         (2) 
In which Ox1/Red1 and Ox2/Red2 are the aqueous and organic redox couples, respectively. 
A simple IT reaction involves reversible transfer of a cation or anion between two immiscible 
liquid phases. If one of the two phases typically, the organic solvent contains a ligand L that 
can react with ion X to form a complex, such a reaction can assist the transfer of X. 
)()()( orgXorgnLaq LX n⇔++                                                        (3) 
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Fig 5: Schematic of voltammetric experiments at (a) a macroscopic and microscopic ITIES supported 
at (c) a microhole and at (e) a micropipette. (b, d, and f) The corresponding cyclic 
voltammograms. Adapted from Liu & Mirkin [48]. 
 
 
 
 
19 
 
Assisted IT reactions usually require less driving force (i.e., lower external voltage) than the 
simple transfer of the same ion. When the interfacial area is large, a four-electrode setup (Fig 
5a) is necessary to minimize the potential drop in a resistive organic solvent [5,49].  
When looking at cyclic voltammograms of IT and ET reactions at the macro-ITIES Fig 5b, 
they look similar to conventional voltammograms obtained at metal electrodes. As such, the 
height of a voltammetric peak is still proportional to the concentration of one of the reactants, 
whose diffusion is rate-limiting, and to the square root of the potential sweep rate. In the case 
of micrometer-sized interface i.e. micro-ITIES, the resistive effect is less important, and the 
easier two-electrode set-up represented in Fig 5c and 5e can therefore be used [50].  
In such experiment, the current is limited by the spherical diffusion of a reagent to a 
micrometer-sized orifice of a microhole Fig 5c or a micropipet Fig 5e and sigmoidal steady-
state voltammograms can be obtained (Fig 5d and 5f. The diffusion limiting current is 
proportional to the reagent concentration and independent of the potential sweep rate. In the 
case where the linear diffusion of ions inside the narrow shaft of a pipet is rate-limiting, peak-
shaped voltammograms are obtained with micropipets as in Fig 5f [48]. 
The presence of the second liquid phase usually augments versatility to electrochemical 
experiments at the ITIES. A large group of IT reactions occur at the ITIES but not at solid 
electrodes. Reactions involving substances of different polarities can be conducted, and the 
permeation of ionic species through bio membranes can be modeled. 
3.2 Amperometric sensors and detectors 
In the ITIES, the equilibrium potential difference is determined by the activities of the 
common ion when it is present in both liquid phases just like in potentiometric ion-selective 
electrodes (ISEs). Moreover, the diffusion-controlled IT current at the ITIES is proportional 
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to the concentration of the transferred ion. Thus, the ITIES can also be used as an 
amperometric ISE [51].  
Because their selectivity may be tailored by the polarization potential, amperometric systems 
possess an advantage over a potentiometric ISEs. It is therefore possible to determine two or 
more ions simultaneously if their half-wave potentials are reasonably well separated. An 
example is an amperometric ISE using a nitrobenzene/water ITIES for the determination of 
K+ and Na+ in drinking water [48]. Some of these devices already on the market have been 
used for measuring various analytes in food, pharmaceutical products, toxic water, and 
industrial samples [52]. 
Unfortunately, wider development of transducers based on ITIES has been used toxic and 
high-electrical resistive organic solvents, and by the mechanical instability of liquid/liquid 
interfaces. To solve the toxicity problem, less toxic solvents, such as 2-nitrophenyloctylether, 
are replacing traditional media, such as nitrobenzene or 1,2-dichloroethane [48]. 
Micro-ITIES can be used to minimize the ohmic potential drop problem and analyze small 
samples. For example, Osborne et al. used a microhole-based ITIES Fig 5c to determine 
aqueous NH4+ at the water/1,2-dichloroethane (DCE) interface [53].  
Ammonium’s transfer was assisted with DB18C6. Because the ionophore concentration in 
the organic phase was high, the measured steady-state current was proportional to the 
concentration of NH4+ in the aqueous phase [54]. 
Ammonium’s transfer was assisted with DB18C6, because the ionophore concentration in the 
organic phase was high, the measured steady-state current was proportional to the 
concentration of NH4+ in the aqueous phase [54]. 
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Ohkouchi, Kakutani, Osakai, & Senda investigated the transfer of acetylcholine (Ach+) by 
steady-state voltammetry at the tip of a micropipette at a nitrobenzene/water interface [55]. 
Both the height of the sigmoidal wave for the Ach+ transferred into the pipet and the peak 
current of the reverse IT reaction were proportional to the bulk concentration of Ach+ in 
water.  
An experimental approach similar to conventional stripping voltammetry improved the 
sensitivity of ion detection. During the first step (~1 min-long accumulation), a sufficiently 
negative potential was applied to the nitrobenzene-filled pipet to induce Ach+ to enter from 
the outer aqueous solution. This was followed by a potential sweep in the positive direction, 
which expelled Ach+ from the pipet. 
With ion concentration in the aqueous phase down to 5 µM Ach+, the peak height was 
proportional to the square root of the accumulation time. Using a similar technique, Katano & 
Senda determined nano molar concentrations of polyoxyethylene nonionic surfactants [56]. 
The stripping voltammetric technique was also successfully used at macro-ITIES for 
determining Hg (II) and Pb (II) in water, with detection limits as low as 1.6 ppb and 1 ppb, 
respectively [57]. 
A lot of work has been done to increase the mechanical stability of liquid/liquid systems by 
gelling the organic or aqueous phase [52]. Typically, the organic phase has been solidified by 
adding polyvinylchloride (PVC), and the aqueous phase has been solidified by adding agar. 
Different gelling agents, such as 1,3:2,4-dibenzylidene sorbitol, have also been used to 
prepare organic gels with ionic conductivities similar to electrolyte solutions [58]. Although 
the diffusion coefficients of ions in gels are significantly reduced, the IT processes could still 
be used for amperometric detection. 
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The gelation of the organic phase often increases resistivity, which impedes amperometric 
determination. Using arrays of liquid/liquid micro interfaces could lessen this problem [54]. 
Urea and creatinine sensors based on amperometric detection of NH4+ were fabricated using 
this approach. 
Recently, Lee, Beattie, Seddon, Osborne, & Girault prepared micro fabricated composite 
polymer membranes, which combine the advantages of the gelled organic phase and micro-
ITIES [59]. The composite membrane consists of a thin, inert, micro perforated polymer 
layer, which is covered by PVC-2- nitrophenyloctylether (PVC-NPOE) electrolyte gel. The 
composite membrane electrode can be incorporated into a flow cell.  
The IT behavior of the microhole array interface between an analyte solution and a PVC gel 
electrolyte was similar to that of a conventional micro-ITIES. When the composite polymer 
membrane was used for the amperometric sensing of choline, the plot of the diffusion-
limiting current against the concentration was linear over the range 0.1– 0.9 mM [59]. 
Sensors for alkali metal ions were produced by adding ionophores (e.g., DB18C6, 
valinomycin) to the PVC membrane [60]. 
Another approach to stabilizing the liquid/liquid interface is to insert a thin, porous, 
hydrophilic Another approach to stabilizing the liquid/liquid interface is to insert a thin, 
porous, hydrophilic or hydrophobic membrane between the two phases [61]. Such a 
membrane-stabilized ITIES was used as an amperometric sensor for the flow-injection 
analysis (FIA) of alkali metal ions, halides, and other anions [61–63]. A successful, 
simultaneous determination of K+ and Na+ in blood serum suggests promising applications of 
this approach for clinical analysis [62]. 
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The ITIES can be used to detect ionic solutes in FIA and HPLC, In ion-exchange 
chromatography, a composite polymer membrane showed detection limits similar to those of 
a conventional conductivity detector [64]. However, an amperometric detector based on a 
micro-ITIES can offer even higher selectivity by choosing the proper ionophore. For 
example, introducing an NH4+-selective ionophore, such as valinomycin, into the gel 
membrane substantially increases the selectivity of the detector toward NH4+ in the presence 
of excess Na+ [64]. 
A composite polymer membrane detector has been used for the FIA of halides, NO3–, and 
SO4-2 [65]. By using the dual-potential-pulse mode and pure water as an eluent, the detection 
limit for the anions could be lowered to the parts-per-trillion level. More recently, a 
microhole-based ITIES amperometric detector for capillary zone electrophoresis determined 
choline and Ach+, and aryl sulfate and sulfonate anions in four different determinations [66]. 
The detection limit in all cases was ~1 µM. 
An ITIES supported at a dual-pipet consisting of two closely spaced pipets filled with 
aqueous solutions and separated by a sub micrometer-wide band of glass [67] was used as a 
gas sensor [68]. When the outer glass surface is not salinized, the pipet orifices are linked by 
a thin aqueous film on the outer pipet wall. Such a film can be sufficiently thick and 
conductive to yield reasonable quality voltammetric responses that are suitable for qualitative 
and quantitative analytical determinations.  
The response of a dual pipet is largely determined by the properties of the aqueous surface 
layer and is very sensitive to changes in film composition. Such changes occur when the pipet 
is exposed to a soluble gas. 
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The IT voltammograms of NH4+ and NO3– were obtained with a dual pipet in which one 
barrel was filled with an aqueous solution and the other with an organic phase exposed to 
vapors of NH3 and HNO3 [68]. The IT current was linear with the concentration of analyte in 
the vapor generating solution. The surface liquid layer in all the pipets used in this work was 
aqueous, and only the detection of water-soluble gases was discussed. However, it may also 
be possible to detect organic compounds in the gas phase using a dual pipet with a no 
aqueous sensing film. 
3.3 Ion partitioning and drug delivery testing 
The pharmacological activity of a drug is largely determined by its ability to permeate lipid 
cell membranes. Permeation depends on the physicochemical properties of the drug, 
particularly on its lipophilicity, which is conventionally evaluated from the drug partitioning 
between water and octanol [69].  
Because octanol can form hydrogen bonds, the water–octanol partitioning of a polar 
substance may not always be a good measure of lipophilicity. Hence, a drug’s ability to 
permeate cell membranes or cross the blood–brain barrier does not always correlate well with 
its water–octanol partition coefficient [51]. 
The partition coefficient, P, of an ion species, i, in a biphasic system is defined as:  
a
ap
w
i
o
i
i =                                                                                   (4) 
In which “a” is the activity of the ion in the organic, o, and aqueous, w, phases. At 
thermodynamic equilibrium, the partition of an ionic species is described by the Nernst 
equation: 
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In which φ∆wo is the interfacial voltage, φ oiwo∆ is the standard IT potential, and zi is the 
charge of the ion. When Equations 3 and 4 are combined and rearranged, lipophilicity can be 
measured directly by: 
φ oiwoioi RT
F
p z ∆−=In                                                                                             (6) 
In which poiIn  is the partition coefficient when the interface is not polarized (i.e., φ∆
w
o
 = 0). 
For a reversible transfer of a simple ion, φ oiwo∆ is related to the half-wave potential by: 
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Thus, the partition coefficient of an ion can be assessed from cyclic voltammograms, and the 
half-wave transfer potential of an ionizable compound can be used to characterize its 
lipophilicity. The value of φ∆wo  1/2 can be easily found from an experimental voltammogram 
because it is equal to the mid peak potential, 2)( φφ ∆∆ + pcpa , in which φ∆ pa  and φ∆ pc  are 
the anodic and cathodic peak potentials, respectively.  
Hence, IT voltammetry at the ITIES is a suitable technique for evaluating the lipophilicity of 
ionic drugs [48]. Extensive voltammetric studies of local anesthetics, such as procaine; 
antihistamines, for example, doxylamine; and uncouplers, such as 2,4-dinitrophenol, have 
been reported [49]. 
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Assuming that the transfers of all relevant species across the ITIES are diffusion-controlled, 
theoretical φ
2
1∆wo versus pH dependences were obtained and used to evaluate the 
physicochemical properties of drugs. Reversible Nernstian behavior was demonstrated for 
different types of drugs.  
For example, in cyclic voltammograms of procaine at the interface between nitrobenzene and 
10-mM aqueous acetate buffer, the anodic peak height was proportional to the square root of 
the potential scan rate within the range 5–100 mV/s, and the peak potential separation was 
close to the 58-mV value, which is characteristic of the reversible univalent IT.  
The partition coefficient of procaine, the formal transfer potential of protonated procaine, and 
the dissociation constants of the first and second protonation–deprotonation reactions were 
obtained from the half-wave potential versus pH dependence. 
The relationship between pharmacological activity and half-wave transfer potential has been 
established for a number of ionizable drugs [5]. For example, many barbiturate derivatives 
are weak acids and are transferred across the ITIES as anions. The φ
2
1∆wo  of these ions 
becomes more positive with an increase in lipophilicity.  
Conversely, of φ
2
1∆wo for some cationic anesthetic drugs becomes more negative with 
increasing lipophilicity. In either case, the higher lipophilicity corresponds to greater 
pharmacological activity. A strong correlation between the pharmacological activity and the 
half-wave potential was found for the families of hypnotic, anesthetic, cholinergic, and 
adrenergic drugs [5]. 
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Many drugs are weak electrolytes that can undergo protonation–deprotonation reactions. The 
transfer of such species across the ITIES depends on the interfacial potential drop, the pH of 
the aqueous phase, and the drug’s dissociation constant. Lee et al. constructed ionic partition 
diagrams Fig 6 that define the domains of predominance for all the species present in the 
aqueous and organic phases as a function of interfacial voltage and aqueous pH [70].  
Partition diagrams offer a simple way to visualize all species at the ITIES, predict the nature 
of the transferring species, and describe the transfer mechanism of ionizable solutes. Such 
information can greatly improve our understanding of how drugs cross cellular membranes to 
reach their biological targets. 
 
Fig 6: Ionic partition diagram showing transfer mechanisms of various forms of quinidine at the 
DCE/water interface. Adapted from Frederic Reymond et al. [70].. 
HQH22+, HQH+, HQ, and Q– stand for the doubly protonated, singly protonated, neutral, and 
deprotonated species, respectively. The solid red lines are the theoretical equiconcentration 
lines between two adjacent species. The blue lines a and b define the potential limits beyond 
which Li+ and TBA+ transfer preferentially. The domain above pH 14 (blue line c) is beyond 
experimental reach. 
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3.4 Cyclic voltammetry (CV) 
Cyclic voltammetry (CV) is a very useful electrochemical technique in every parts of 
chemistry, for example the characterization of electroactive species in modern analytical 
chemistry, electrochemistry, and biochemistry [71]. 
Cyclic voltammetry provided information about the electroactive species by measuring the 
faradic current as a function of applied potential. The current response is measured by 
applying a potential ramp starting from an initial potential to a first switching potential and at 
this potential the direction of the potential is reversed and the same potential range is scanned 
in the opposite direction (hence the term “cyclic”). On the process, the electro active species 
formed by reduction or oxidation depending on the direction can be oxidized or reduced or on 
the reverse scan. 
Cyclic voltammetry is usually performed in three electrode arrangement (the working 
electrode usually being Pt., Au or GC electrode), counter or auxiliary electrode and reference 
electrode (in aqueous solution Ag/AgCl and SCE). The potential is applied to the working 
electrode with respect to a reference electrode and the current is measured between the 
counter and working electrode [71,72]. The current measured between the working electrode 
and the counter electrode is plotted against the applied potential relative to the reference 
electrode to give the cyclic voltammogram. Usual cyclic voltammograms of a reversible 
processes is shown in Fig 7. 
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Fig 7: Typical CV of a reversible process. 
The following equations can be used for a reversible process to evaluate the electrochemical 
parameters’ from cyclic voltammetry.  
Randles –Sevcik equation: [ ] vni CDRTFFAp 21212321446.0=    (8) 
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Where i p  is peak current/A, F is Faraday constant (96, 487 C/mol), D is diffusion 
coefficient/cm/s of the electroactive species, A is the area of the electrode/cm2, ʋ is the sweep 
rate/V/s, R is the general gas constant (8.413 J/mol K) and T is temperature C°25 ). 
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CHAPTER IV: EXPERIMENTAL 
4.1 Chemicals 
• Acetonitrile (Sigma-Aldrich, ≥99.9%, product#34998) 
• NH4Cl (Merck, 99.8%, product# AC001145) 
• (NH4)2SO4 (Kimix, 99%, product #47k12/0410) 
• 1-Butyl-3-methyl-Iimidazolium bis(trifluoromethylsulfonyl)Imide (Merck, product# 
S5205492031) 
• Dibenzo-18-Crown-6 (Fluka, ≥98%, product# 33531) 
• 1, 2 Dichloroethane (Sigma-Aldrich, ≥99%, product # 319929) 
• Ethyl Violet (Sigma-Aldrich, product#228842) 
• Li2SO4 (Sigma-Aldrich, ≥98.0%, product# 62613) 
• Methyltrioctylammonium bis(trifluoromethylsulfonyl)imide (Fluka, ≥97%, product# 
00797) 
• MgSO4 (Sigma-Aldrich, ≥99.5%, product# M7506) 
• Nitrobenzene (Fluka, ≥99.5%, product # 7298). 
• 2-Nitrophenyl octyl ether (Fluka, ≥99%, product#73732) 
• KCl (Sigma-Aldrich, ≥99.9%, product#P-3911). 
• K2SO4 (Kimix, 99%, product# k1710311) 
• 1-Propyl-3-methyl-limidazoliumbis(trifluoro-methylsulfonyl)imide(Merck, 
product#EQ413728850) 
• Sodium tetraphenylborate (Sigma-Aldrich, ≥99.5%, product# T25402) 
• Tenofovir disoproxil fumarate as brand name Viread, (tablets) was obtained from M-
KEM Medicine City, Bellville. 
• Tetrabutylammonium tetraphenylborate (Sigma-Aldrich, 99%, product# 281034) 
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• Tetradodecylammonium tetrakis(4-chlorophenyl)borate (Fluka, product# 87255) 
• Tetraphenylphosphnium tetraphenylborate (Fluka, product # 88065) 
4.2 Materials 
A cellulose tube dialysis sack (Product # 250-7U, SIGMA Diagnostics, Inc, St. Louis, USA) 
was adapted as membrane in the liquid-liquid interface based sensor used in this study. The 
specified cut-off size for retention of proteins was 12000. It was always stored dry at 18-26 
C° in a vacuum desiccator. A measured (2.5 cm x 2.5 cm) piece of the flattened dry 
membrane was cut off, sliced into halve, and moisten with water immediately before use.  
The Teflon rods used for constructing sensor body (or organic phase holder) were obtained 
from MAIZEY, Bellville (Stikland), South Africa 
Silver and platinum wires were obtained from Sigma Aldrich 
4.3 preparations of solutions  
An ultrapure de-ionized (DI) water (18 MΩ cm) produced by a reverse osmosis/ ion-
exchange combined water purification system (Rios TM 3/ Synergy, Millipore) was used for 
the preparation of all reagent solutions and experimental steps where necessary. 
Aqueous lithium sulphate (100 mM) 
100 mM of lithium sulphate solution was prepared by dissolving 1.0902 g of lithium sulphate 
salt in 100 mL volumetric flask with of deionised (DI) water). 
Aqueous Ammonium chloride (1000 mM) 
The mass of 1.0993 g ammonium chloride salt was dissolved in 10 mL volumetric flask with 
DI water to prepare 1000 mM of ammonium chloride solution.  
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Aqueous Potassium chloride (100 mM) 
Potassium chloride solution, 100 mM was prepared by dissolving 0.7450 g of potassium 
chloride salt into 100 mL volumetric flask with DI water.  
Aqueous Magnesium sulphate (100 mM) 
100 mM of magnesium sulphate solution was prepared by dissolving 1.2038 g of magnesium 
sulphate salt in a volumetric flask (100 mL) with DI water. 
Aqueous Ammonium sulphate (50 mM) 
0.06607 g of ammonium sulphate was dissolved in 10 mL DI water to prepare 50 mM of 
aqueous ammonium sulphate solution. 4.3.6 Aqueous Potassium sulphate (50 mM) 
Aqueous Potassium Sulphate (50 mM) 
The solution of 50 mM potassium sulphate was prepared by dissolving 0.8713 g of potassium 
sulphate salt with DI water in 100 mL volumetric flack.  
4.4 Preparation of organic electrolyte solutions 
In this study nitrobenzene (NB), 1, 2-dichloroethane (DCE) and 2-nitrophenyloctyl ether 
(NPOE) were used as solvents to prepare the following hydrophobic electrolyte solutions 
(organic phase) which were always stored in the dark. When indicated these solutions were 
also equilibrated with DI water.  
Preparation of 10 mM ETH500 in NB 
0.1361 g of ETH500 powder was dissolved with 10 mL of NB measured using micro-pipette 
into a brown glass bottle 
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Preparation of the mixture of 10 mM ETH500 and 50 mM DB-18-C-6 in NB 
0.1361 g of ETH500 and 0.1802 g of DB18C6 were dissolved in 10 mL of NB with or few 
minutes of gentle shaking to homogenize the solution. 
Preparation of 10 mM TBATPB in NB  
The solution of 10 mM of TBATPB was prepared by dissolving 0.0323 g of TBATPB 
powder with 5 mL of NB into a brown glass bottle. 
Preparation of 10 mM TPphTPB in NB  
0.0538 g of TPphTPB was dissolved 5 mL of NB in a brown glass bottle containing.  
Preparation of 10 mM IL1 in NB  
296 µL of IL1 was pipette out into a brown glass bottle containing 5 mL of NB and shaken 
gently to homogenize the solution. 
Preparation of 10 mM EthVTPB in NB  
EthVTPB was prepared based on a procedure adapted from in the literature [73,74] 0.6954 g 
of ethyl violet and 1 g of sodium tetraphenylborate were mixed together in DI water in 
stoichiometric amounts under stirring at 25°C. After three hours, a blue solution was obtained 
and filtered using suction filtration (Fig. 8) and washed with small quantity of DI water. The 
resulting filtrate was left at room temperature for drying and the blue powder of EthvTPB 
with iridescent green surface was. 0.0354 g of this product was weighed out into a brown 
glass bottle and dissolved in 5 mL NB. 
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Fig 8: Suction filtration set-up (Adapted from ref [75]) 
Preparation of 10 mM ETH500 in DCE  
0.0572 g of EHT500 was dissolved into brown glass bottle with 5 mL of DCE and 10 mM of 
ETH500 solution was prepared. 
Preparation of 10 mM IL1 in DCE  
The volume of 296 µL of IL1 was pipette into a brown glass bottle and 5 mL of DCE was 
added with micro-pipette also. The mixture was shacked and 10 mM of IL1 solution was 
obtained. 
Preparation of 10 mM ETH500 in NPOE  
10 mM of ETH500 solution was prepared by dissolving 0.1140 g of ETH500 powder into a 
brown glass bottle with 10 mL of NPOE. 
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Preparation of 10 mM IL1 in NPOE  
296 µL of IL1 was pipette out into a brown glass bottle and 5 mL of NPOE was added, the 
resulting mixture was gently shaken to homogenize it, and always stored in the dark. 
Preparation of tenofovir solution10 mM 
From the literature, it was found that the tenofovir dissolve in water at 25Cº and methanol 
[76,77],one tablet was weighed correctly (0.6995 g) and crushed to fine powder using mortar 
and pestle. An accurately weighed powder equivalent to 0.6485 g of tenofovir was transferred 
to 50 mL volumetric flask and volume made up to 47 mL with DI water. After that the 
solution was centrifuged for 20 minutes (speed×1000, 14.5 rpm) adopted from literature [76]. 
From this stock solution another sample solution of drug was prepared (0.1 mM) by dilutions 
with DI water. The solution stored in freezer +8Cº. 
 
Fig 9: Centrifuge  
4.5 Instrument 
Cyclic Voltammetry (CV) experiments were carried out using a MOD-7050 potentiostat 
(AMEL instrument, Milano Italy) connected to a personal computer through a USB 
electrochemical interface. All measurements were made at 25oC.  
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4.6 Liquid-Liquid Interface Ion Transfer Electrochemical Cell Set-up 
An in-house made PTFE-based tubular nut (tip i.d. = 4 mm), bolt, and O-ring kit was used t 
constitute a four-electrodes cell shown in Fig 7 with two reference electrodes, one in the 
organic (O) phase and the other in aqueous (W) phase (between which applied potentials 
were measured), and two corresponding counter electrodes to carry and measure the current 
flow across the O/W interface. The reference electrode in organic phase was merely a Ag 
wire pseudo reference electrode; the reference electrode in aqueous phase was Ag/AgCl or 
Ag/Ag2SO4 as indicated. Both counter electrodes were Pt wires. Various hydrophobic 
electrolytes were employed to serve as the organic phase, but mostly those composed of 
either of NB, 1, 2-DCE and NPOE and 10 mM of a hydrophobic salt, particularly ETH500 
with or without the ionophore DB18C6 (50 mM). The aqueous phase was either aq. Li2SO4 
or aq. MgSO4 at 50 mM or 100 mM concentration.  
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Fig 10: Photograph of parts of the organic phase device (left) and the assembled four-electrode cell (right) for studying membrane stabilized liquid-liquid 
Interface ion-transfer electrochemical cell: Pt wire counter electrodes (1 and 3), PTFE tubular-bolt (2), PTFE nut (4), Ag-wire pseudo reference electrode (5) 
for organic phase, Ag/AgCl or Ag/Ag2SO4 reference electrode (6)  for aq. phase, dialysis membrane (7), and PTFE O-ring (8) 
(1) 
(4) 
(3) (6) 
(5) 
(8) 
(7) 
(2) 
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Fig 11: Photograph of cell connected with AMEL instrument and the output shows in the PC. 
4.7 Preliminary studies   
The project was started with preliminary studies with the objective of screening different 
traditional solvents (NB, DCE and NPOE), hydrophobic salts (ETH500, TBATPB, 
TPphTPB, EthVTPB) as well as ionic liquids (IL1, IL3 and IL4) for organic phase 
applications in the envisaged polarizable liquid-liquid interface-based sensors for tenofovir. 
CVs of the interfaces of these solutions with aq. Li2SO4 were recorded, both in the absence 
and the presence of K+ and NH4+ ions, and of tenofovir (if indicated) in the aq. phase. 
Initially only NB was used as the only solvent to compare these salts in NB. Whereas the 
pure ILs were first tested as self-sufficient organic electrolytes. As IL1 was found to form the 
most polarizable interface with aq. Li2SO4, its solution in NB was then tested against the 
same aq. phase. Two parameters used to measure the relative friendliness of a liquid-liquid 
interface to sensor applications were: potential window and capacitance. Two salts were then 
selected and their solutions in NPOE and DCE were compared similarly. This time, the 
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ionophore DB18C6 was also incorporated as the third component of the organic phase. Aq. 
MgSO4 was later on tested as additional hydrophilic salt. It will be shown that, also based on 
extra-electrochemical consideration, the most suitable organic phase was the solution of 
ETH500 in DCE against aq. MgSO4.  
  
4.8 Analytical operation and performance of liquid-liquid interface sensor for tenofovir 
Cyclic voltammetry is a fast electroanalytical technique used in electrochemical sensor not 
only to detect and quantify an analyte, but also to estimate its kinetic and thermodynamic 
properties. Therefore, additional CVs in the presence of tenofovir (0.2 mM) in the aq. phase 
were recorded at different scan rates without with DB18C6 in the organic phase in order to 
demonstrate the detection of the analyte and evaluate the rate limiting step in its transfer 
across the interface. In addition, the stability of sensor was studied by running time-laps CVs 
for about 3 hours at same scan rate and fixed concentration of tenofovir. From this 
experiment the suitable time for conditioning the sensor for reproducibility was found. As 
well as linearity ranges and detection limits, partition coefficients of tenofovir were evaluated 
from the data of peak heights and peak potentials vs concentrations collected at a selected 
(optimal) scan rate.  
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CHAPTER V: RESULTS AND DISCUSSIONS 
Ion transfer amperometric studies were carried out with a four-electrode cell and various 
membrane-stabilized liquid-liquid interfaces between a hydrophobic electrolytes solution 
(organic (O) phase) and two hydrophilic electrolyte solutions (water (W) phases). The O 
phases were composed of the hydrophobic salts ETH500, TBATPB, EthvTPB, TPphTPB, as 
well as three hydrophobic ionic liquids (IL) dissolved in three different polar hydrophobic 
solvents, namely, nitrobenzene (NB), dichloroethane (DCE), and nitrophenyloctylether 
(NPOE). The W phases studied were aq. Li2SO4 and MgSO4. The three ILs were also tested 
without the need to incorporate an additional hydrophobic salt.  
CV of K+ and NH4+ added to the W phase were also measured for reference potential as well 
as for performance evaluation purposes. Since the main aim of the research was to develop 
sensors, the construction of the four electrode cell was simplified by simply using a Ag wire 
pseudo reference electrode (RE) in the organic phase (Ag(O), while in the aqueous phase a 
standard Ag/AgCl or homemade Ag/Ag2SO4 REs were employed. As a result of this the 
potentials measured in this manuscript do not solely represent the potential across the O/W 
interface (∆WOϕ) unlike those in the literature, where identical reference electrodes are used 
in both O and W phases may somehow offset each other. Thus, in this work all CV will 
appear shifted by amount of an error, which indeed won’t matter for our purposes. The 
potentials reported in this manuscript, symbolized as E, were measured from the point of 
view of the Ag(O) relative to aq. phase RE’s (Ag/AgCl or Ag/Ag2SO4). Therefore E would 
represent the total potential given by:  
errorEEEEE OwWclAgClAgOAg
O
wWclAgClAg
O
wOAg +∆=−+∆=−∆+= −− ϕϕϕ )()( )(,||)(,||        (12) 
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The notation of the studied hydrophobic electrolyte (also O-phase) systems and its two 
electrodes (Ag RE, Pt CE) and supporting hydrophilic cellulose membrane/ liquid-junction 
(||) will be simplified as “Ag| salt (x mM)/ O||” or Ag| salt (x mM)/ ionophore (y mM)/ O||”, 
and will be referred to as “sensor 1” and sensor 2, respectively. The existence of the Pt 
counter electrodes should be simply understood. Both sensor 1 and 2 are dipped in aq. 
electrolyte phase (also W phase) to form an O/W interface and CVs are recorded by changing 
the potential difference across this interface ( )ϕOw∆  to derive a net ion transfer from one 
phase to the other, resulting in the observation an electrical current between the two counter 
electrodes. 
5.1.Preliminary investigations  
Four hydrophobic salts (ETH500, TBATPB, EthvTPB, and TPphTPB) and ILs were tested as 
supporting electrolytes (in each case 10 mM) in NB to find out the one which is most suitable 
with respect to width of the potential window and double layer capacitance noise. 
Background cyclic voltammograms (CVs) of membrane-stabilized interface between aq. 
Li2SO4 and NB containing the above hydrophobic salts were initially recorded and compared 
to this end. 
 
5.1.1 Evaluation of traditional hydrophobic salts and ionic liquids 
Tetradodecylammonium tetrakis(4-chlorophenyl)borate (ETH500) 
Fig 12 shows overlay of triplicate CVs of Ag| ETH500 (10 mM)/ NB|| in aq. Li2SO4 (100 
mM). This CV indicates the potential window of this interface spans from -0.25 to 0.35 V. 
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Fig 12: Replicate background CVs of Ag| ETH500 (10 mM)/ NB|| in and aq. Li2SO4 (100 mM). Einitial 
= Efinal = -0.25; Ehigh = 0.35 V; scan rate = 10 mV/ s. 
The limits of the potential window arise because of either of the following simple ion-transfer 
of from water phase to organic phase or the reverse in equation (13 and 14), where A+ and B- 
are ions of the hydrophobic salt in the O phase. 
Cathodic limit:  Li+ (W)  Li+(O)      (13) 
B-(O)  B-(W) 
Anodic limit:  SO42- (W)  SO42- (O)     (14) 
A+(O)  A+(W) 
This mechanism will be valid for all except when an ionophore or other complexing agents 
are incorporated in the organic phase.  
There were no new ion-transfer peak after addition of K+ (4 mM) or NH4+ (4 mM) in the 
aqueous phase (Li2SO4) (see Fig 12). This observation is in agreement with literature as the 
transfer of these ions requires the presence of an appropriate ionophore in the O phase [78]. 
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Fig 13: CVs of Ag|ETH500 (10 mM)/ NB|| before (black) and with 4 mM K+ (red) or NH4+ (green) in 
aq. Li2SO4 (100 mM). Einitial = Efinal = -0.25; Ehigh = 0.35 V; scan rate = 10 mV/ s. 
Tetrabutylammonium tetraphenylborate 
The second hydrophobic salt tested was TBATPB in NB. The corresponding sensor 
configuration is: Ag|TBATPB (10 mM)/ NB||. The CV in this case is shown Fig 12. The CVs 
were repeated to be sure the background was stable before adding the test ions (K+ and 
NH4+). The potential window of this system was established to range from 0.25 to -0.35 V. 
 
Fig 14: Replicate background CVs of Ag|TBATPB (10 mM)/ NB|| in aq. Li2SO4 (100 mM). Einitial 
= Ehigh = 0.25 V; Elow = -0.35 V; scan rate = 10 mV/ s 
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Fig 15 shows an overlay of replicate CVs of this interface in the presence of K+ or NH4+ ions. 
Except for some sort of distortion or changes in background CV shape, there was no obvious 
ion transfer peak. 
 
Fig 15: CVs of Ag|TBATPB (10 mM)/ NB|| before (black) and with 4 mM K+ (red) or NH4+ (green) 
in aq. Li2SO4 ( 100 mM). Einitial = Ehigh = 0.25 V; Elow = -0.35 V; scan rate = 10 mV/ s 
Ethyl Violet tetraphenylborate 
EthvTPB in NB was tested like the previous hydrophobic salts. The corresponding sensor 
configuration is: Ag| EthvTPB (10 mM)/ NB||. Its background CVs during initial experiments 
was not stable as shown in Fig 16A. So a potential-step excitation wave form lasting 10 s was 
imposed immediately before recording the CV and a better CV in Fig 16B was obtained. Fig 
16C shows the same CV after cutting out the noise due to the potential-step, Fig 16D shows 
the system would give a well behaved stable background CV under multicyclic CV 
experiment. In the end a potentials window of -0.6 to -0.05 V was established for this system. 
In addition to, when K+ and NH4+, no simple ion transfer was observed as expected (Fig 17). 
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Fig 16: A) Replicate background CVs of Replicate background CVs of Ag| EthVTPB (10 mM)/ NB|| in aq. Li2SO4 (50 mM). Einitial = Ehigh = 0.6 V, and Elow = 
-0.05 V, scan rate = 10 mV/ s. B) The same as (A) but preceded by a 10 s potential-step of -0.6 V. C) Same as B, but after removing the noise due to 
preconditioning potential-step. D) A multicyclic CV preceded by the same potential-step. 
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Fig 17: CV of Ag|EthVTPB (10 mM)/ NB|| before (green) and with 4 mM of K+ (black) or NH4+ (red) 
in aq. Li2SO4 (50 mM). Einitial = Ehigh = 0.6 V, Elow = -0.05 V; Epre-step = 0.6 V for 10 s; Scan rate = 10 
mV/ s 
Tetraphenylphosphnium tetraphenylborate 
 
Fig 18: Replicate background CVs of Ag|TPphTPB (10 mM)/ NB|| in aq. Li2SO4 (50 mM). Einitial = 
Ehigh = 0.15 V; Elow = -0.35 V; scan rate = 10 mV/ s 
The last traditional hydrophobic salt was TPphTPB in NB (10 mM), used the same method of 
detection. The corresponding sensor configuration is: Ag|TPphTPB (10 mM)/ NB||. Its 
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potential window was from 0.15 to -0.35 V as can be seen from the background CVs overlaid 
in Fig 18. No peaks were observed for K+ and NH4+ in the aqueous phase (see Fig 19).  
 
Fig 19: CVs of Ag|TPphTPB (10 mM)/NB|| before (red) and with 4 mM K+ (black) or NH4+ (green) in 
aq. Li2SO4 (50 mM). Einitial = Ehigh = 0.15 V; Elow = -0.35 V; scan rate = 10 mV/ s 
Ionic liquids 
Similar studies were carried out using three hydrophobic room-temperature ionic liquids 
(ILs): 
• Methyltrioctylammonium bis(trifluoromethylsulfonyl)imide (IL1) 
• 1-Butyl-3-methylimdazolium bis(trifluoromethylsulfonyl)imide (IL3) and 
• 1-Propyl-3- methylimdazolium bis(trifluoromethylsulfonyl)imid (IL4) 
The pure forms of three ILs were first tested as self-sufficient hydrophobic electrolytes. The 
corresponding configurations would be: Ag|IL1||, Ag|IL3||, and Ag|IL4||. However, only one 
(Ag|IL1||) was found to yield a some-how polarizable interface with the aq. phase as one can 
see from Figs 20 and 21. The potential window of Ag|IL1|| in aq. Li2SO4 (50 mM) was from 
0.5 V to 0.1 V. Like the previous hydrophobic electrolyte, no peak was observed when K+ or 
NH4+ was added to the aq. phase. IL1 was then additionally tested as a hydrophobic salt in 
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NB. The CVs of Ag|IL3|| and Ag|IL4|| in aq. Li2SO4 (50 mM) demonstrated these ILs could 
only form a poorly polarizable liquid-liquid interfaces (see Figs 22 and 23). Indeed, the CVs 
exhibited by these two systems were similar with purely resistive elements (see Fig 24).  
 
Fig 20: Replicate background CVs of Ag|IL1|| in aq. Li2SO4 (50 mM). Einitial = Ehigh = 0.5 V; Elow = 
0.1 V; scan rate = 10 mV/ s. 
 
Fig 21: CV of Ag|IL1|| before (black) and with 4 mmM of K+ (red) or NH4+ (green) in aq. 
Li2SO4 (50 mM). Einitial = Ehigh = 0.5 V; Elow = 0.1 V; scan rate = 10 mV/ s 
According to figures 22 and 23, the interfaces formed with IL3 and IL4 were not suitably 
polarized and behaved like resistance in liquid- liquid interface as shown in Fig 24. 
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Fig 22: Replicate background CVs of Ag|IL3|| in aq. Li2SO4 (50 mM). Einitial = Ehigh = -0.22 V; Elow = -
0.02 V; scan rate = 10 mV/ s. 
 
Fig 23: Replicate background CVs of Ag|IL4|| in aq. Li2SO4 (50 mM). Einitial = Ehigh = -0.38 V; Elow = -
0.03 V; scan rate = 10 mV/ s. 
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Fig 24: Replicate CVs of a 1 kΩ resistor. Einitial = Ehigh = -0.38 V; Elow = -0.02 V; scan rate = 10 mV/s.  
Methyltrioctylammonium bis(trifluoromethylsulfonyl)imide (IL1) 
The IL1 was also tested like the traditional hydrophobic salt in NB. The corresponding sensor 
configuration would be Ag|IL1 (10 mM)/ NB||. The CV of the interface it formed with aq. 
Li2SO4 is shown in Fig 25, and its potential window was found to range from 0.27 V to -0.08 
V. No peaks were observed for K+ and NH4+ in the aqueous phase (see Fig 26). 
 
Fig 25: Replicate background CVs of Ag|IL1 (10 mM) /NB|| in aq. Li2SO4 (50 mM). Einitial = Ehigh = 
0.27 V; Elow = -0.08 V; scan rate = 10 mV/ s 
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Fig 26: CVs of Ag|IL1 (10 mM)/ NB|| before (black) and with 4 mM K+ (red) or NH4+ (green) in aq. 
Li2SO4 (50 mM). Einitial = Ehigh = 0.27 V; Elow = -0.08 V; scan rate = 10 mV/ s  
Anodic and cathodic potential limits, thus potential windows, mean background currents (ibg-
mean), and capacitance (Cdl) observed at 10 mV/s scan rate for the above membrane-stabilized 
interfaces (Figs 12 to 25) between solutions of the hydrophobic salts (10 mM) in NB as well 
as pure IL1 and aq. Li2SO4.(50 or 100 mM) have been compiled in Table 8. ibg-mean was 
calculated by taking five different data points from background CVs corresponding to each 
interface. Standard deviations were calculated using equation 15. 
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Table 8: Background currents (ibg), double layer capacitance (Cdl), and potential limits of 
Ag|salt (10 mM)/ NB|| and Ag|IL1|| in aq. Li2SO4 (50/ **100 mM). Scan rate = 10 mV/s. *vs 
Ag/AgCl 
Organic phase ibg-mean / µA (Cdl ±SD)/ µF 
*Anodic 
limit/ V 
*Cathodic 
limit/ V 
Window/ V 
**TBATPB/ NB 
0.44±0.00 a 43.9±0.1 a 
0.25 -0.35 0.60 
-0.24±0.00 c -24.4±0.0 c 
TPPHTPB/ NB 
0.21±0.00 a 21.1±0.2 a 
0.15 -0.35 0.50 
-0.12±0.00 c -12.2±0.3 c 
**ETH500/ NB 
0.24±0.00 a 24.2±0.0 a 
0.35 -0.25 0.60 
-0.04±0.00 c -4.4±0.0c 
ETHVTPB/ NB 
-0.89±0.03 -89±3a 
0.05 -0.60 0.65 
-0.12±0.00 a -12.2±0.1c 
Pure IL1 
2.27±0.00 a 227.2±0.4 a 
0.50 0.10 0.40 
-2.56±0.00 c -255.9±0.5c 
IL1/ NB 
1.05±0.00 a 104.6±0.2a 
0.27 -0.08 0.35 
-1.24±0.00 c -124.4±0.2 c 
The Cdl data in Table 8 have been plotted as bar-graphs in Fig 27 in order to make it much 
easier to identify the salt with minimal Cdl, hence lowest background noise. In Fig 28, both 
potential window and Cdl have been plotted against the corresponding salts. The wider 
potential window is the best it would be. Based on Fig 16, one can see that EthvTPB resulted 
in the widest potential window but its background CV was relatively unstable and 
unsymmetrically off-set, possibly because of excessive impurities. IL1 resulted in highest 
double layer capacitance and the narrowest potential window, both in its pure and NB-
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solution forms, so it would make the least favourable interface with aqueous phase among the 
electrolytes tested in this work. In contrast, ETH500 resulted in the smallest double layer 
capacitance and the second widest potential window. Thus, we can conclude that ETH500 
would be the best choice for developing the envisaged sensor. However, in anticipation of 
any possible surprises, both the best (ETH500) and the worst (IL1) were taken to the next 
stage of the study, in which DCE and NPOE would be tested as solvents in the organic phase. 
 
Fig 27: Bar-graphs of bi-double layer capacitances (Cdl) at Ag|salt (10 mM)/ NB|| and Ag|IL1|| in aq. 
Li2SO4 (50 or 100 mM) observed with different salts 
 
Fig 28: Bi-double layer capacitances (Cdl) and potential windows of Ag|salt (10 mM)/ NB|| and 
Ag|IL1|| in aq. Li2SO4 (50 or 100 mM) observed with different salts 
 
 
 
 
55 
 
5.1.2 Evaluation and selection of hydrophobic solvents: DCE and NPOE against NB 
Solutions of ETH500 and IL1 in DCE and NPOE were similarly tested, each at 10 mM, and the 
results have been discussed below.  
ETH500 in DCE 
Fig 29 shows the background CV of Ag|ETH500 (10 mM)/ DCE|| in aq. Li2SO4 at the scan 
rate of 10 mV/ s, according to which the potential window was found to range from 0.4 to -
0.45 V (vs Ag/AgCl). The overlaid CVs confirm this configuration resulted in reproducible 
background CVs and potentially reproducible signals. No peaks were observed for K+ and 
NH4+ in the aqueous phase (see Fig 30). 
 
Fig 29: Replicate background of CVs of Ag|ETH500 (10 mM)/ DCE|| in aq. Li2SO4 (50 mM). Einitial = 
0.40 V; Efinal = - 0.45 V; Efinal = 0.40 V; scan rate = 10 mV/ s 
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Fig 30: CVs of Ag|ETH500 (10 mM)/ DCE||before (black) and with 4 mM K+(red) or NH4+ (green) in 
aq. Li2SO4 (50 mM).Einitial =0.40 Efinal = -0.45 V; Efinal = 0.40 V; scan rate =10 mV/ s 
IL1 in DCE 
Fig 31 shows the background CV of Ag|IL1 (10 mM)/ DCE|| in aq. Li2SO4 at the scan rate of 
10 mV/ s, according to which the potential window was found to range from 0.4 to -0.06 V 
(vs Ag/AgCl). This configuration also resulted in a reproducible background CV, but the 
window is much narrower. No peaks were observed for K+ and NH4+ in the aqueous phase 
(see Fig 32).  
 
Fig 31: Replicate background CVs of Ag|IL1 (10 mM)/ DCE in aq. Li2SO4 (50 mM). Einitial =  Efinal = 
0.40 V; Elow = -0.08 V; scan rate = 10 mV/ s 
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Fig 32: CVs of Ag|IL1 (10 mM)/ DCE|| before (black) and with 4 mM K+ (red) or NH4+ (green) in aq. 
Li2SO4 (50 mM). Einitial = Efinal = 0.40 V; Elow = -0.08 V; scan rate = 10 mV/ s 
ETH500 in NPOE 
Fig 33 shows the background CV of Ag|ETH500 (10 mM)/ NPOE|| in aq. Li2SO4. The CVs 
are reproducible but appear distorted, possible because this electrolyte has a high resistance. 
Thus, the potential window range would be narrower than it appeared to be (0.45 V to -0.65 
V vs Ag/AgCl). No peaks, but a slight distortion was observed on addition of K+ and NH4+ in 
the aqueous phase (see Fig 34). 
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Fig 33: Replicate background CVs of Ag|ETH500 (10 mM)/ NPOE|| in aq. Li2SO4 (50 mM). Einitial =  
Efinal = 0.45 V; Elow = -0.65 V; scan rate = 10 mV/ s 
 
Fig 34: CVs of Ag|ETH500 (10 mM)/ NPOE|| before (black) and with 1 mM K+ (red) or NH4+ (green) 
in aq. Li2SO4 (50 mM). Einitial =  Efinal = 0.45 V; Elow = -0.65 V; scan rate = 10 mV/ s 
IL1 in NPOE 
Fig 35 shows the background CV of Ag|IL1 (10 mM)/ NPOE|| in aq. Li2SO4. The CVs are 
less reproducible and appear more severely distorted than that of ETH500/NPOE, indicating 
an even higher electrolyte resistance. The apparent potential window would be 0.5 V to -0.2 
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V vs Ag/AgCl. No peaks, but, compared to ETH500/NPOE, a greater degree of distortion 
was observed in the background CV after addition of K+ and NH4+ in the aqueous phase (see 
Fig 36). 
 
Fig 35: Replicate background CVs of Ag|IL1 (10 mM)/ NPOE|| in aq. Li2SO4 (50 mM). Einitial = Efinal 
= 0.5 V; Elow = - 0.2 V; scan rate = 10 mV/ s 
 
Fig 36: CVs of Ag| IL1 (10 mM)/ NPOE|| before (black) and with 4 mM of K+ (red) or NH4+ (green) 
in aq. Li2SO4 (50 mM). Einitial = Efinal = 0.5 V; Elow = - 0.2 V; scan rate = 10 mV/ s 
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Inter-comparison among NB, DCE, and NPOE 
To facilitate the identification of the most favourable hydrophobic solvent among NB, DCE, 
and NPOE, based on the preceding CVs, the corresponding Cdl and potential windows have 
been plotted in the Fig 37 and Fig 38. Anodic/ cathodic potential limits and potential window 
ranges (or simply: windows) have been compiled in Table 8. As one can see the ETH500/ 
NPOE pair resulted in the widest potential window, but the second smallest Cdl. The 
ETH500/DCE pair resulted the smallest Cdl but in the second widest potential window. 
ETH500/ DCE had smaller Cdl and wider potential window than ETH500/ NB. IL1/ NB, IL1/ 
DCE, and IL1/ NPOE had the smallest potential windows and highest Cdl values, and, thus, 
these are least favourable ones.  
 
Fig 37: Bar-graphs of bi-double layer capacitances (Cdl) observed for Ag|ETH500 or IL1 (10 mM)/ 
solvent|| in aq. Li2SO4 (50 or 100 mM) across solvents (NPOE, DCE, and NB) 
If it were only for pure quantitative considerations, one would find the ETH500/ NPOE pair 
to be the most favourable organic phase. However, the ETH500/ DCE pair could also be 
more favourable because of the following two reasons (a) the fact that the CV of this phase 
was very distorted meant it suffered high resistive loss resulting in a positive error in the 
value of the potential window, and (b) economic reason (according to Sigma Aldrich at the 
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time of writing this manuscript, the price for 25 mL of NPOE was R 1248.62 while that of 
500 mL of DCE was R 283.13). However, both the ETH500/DEC and ETH500/NPOE phases 
will be employed in the next stage of the study in which aq. Li2SO4 will be evaluated against 
aq. MgSO4. 
 
Fig 39: Bar-graphs of Cdl and potential windows observed for Ag|ETH500 or IL1 (10 mM)/ solvent|| 
in aq. Li2SO4 (50 mM) across solvents (NPOE, DCE, and NB) 
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Table 9: Potential limits (vs Ag/AgCl) observed at 10 mV/s scan rate for Ag|ETH500 or IL1 
(10 mM)/ solvent|| in aq. Li2SO4 (50 mM) across solvents (NPOE, DCE, and NB). 
Solvent Salt 
Anodic limit/  
V 
Cathodic limit/ 
V 
Window/  
V 
Cdl-a/ 
 µF 
Cdl-c/  
µF 
DCE 
ETH500 0.40 -0.45 0.85 17 -1.03 
IL1 0.40 -0.08 0.53 183.34 -185.37 
NPOE 
ETH500 0.45 -0.65 1.1 15 -9.78 
IL1 0.50 -0.20 0.70 96.59 -26.98 
NB 
ETH500 0.35 -0.25 0.60 24.2 -4.4 
IL 1 0.27 -0.08 0.35 104.6 -124.4 
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5.1.3 Evaluation of two aqueous phases 
The CV characteristics of the sensors with ETH500/DCE and ETH500/NPOE organic phases 
were compared in two aq. phases, namely aq. Li2SO4 and aq. MgSO4. Hence forward, unless 
otherwise indicated, Ag/Ag2SO4 was used instead of Ag/AgCl as the aq. phase reference 
electrode to avoid possible effects of the Cl- on the anodic limit. 
 
Fig 40: Replicate background of CVs of Ag|ETH500 (10 mM)/ NPOE|| in aq. MgSO4 (50 mM) 
phases. Einitial = Efinal= 0.40 V; Elow= -0.60V; scan rate = 10 mV/ s 
 
Fig 41: Replicate background of CVs of Ag|ETH500 (10 mM)/ DCE|| in aq. MgSO4 (50 mM) phases. 
Einitial = Efinal= 0.40 V; Elow= -0.60V; scan rate = 10 mV/ s 
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The notations of the sensors studied here would be: Ag|ETH500 (10 mM)/ DCE|| and 
Ag|ETH500 (10 mM)/ NPOE||. In Table 10, potential limits and windows of these ones in aq. 
Li2SO4 and aq. MgSO4 have been compiled based on Fig. One can see that wider potential 
windows were obtained in aq. MgSO4 in contrast with aq. Li2SO4. Besides NPOE still 
resulted in apparently wider windows, but this time only wider by about 50 mV and also that 
the corresponding CVs in aq. MgSO4 (see Fig 40) are as distorted as the ones observed in aq. 
Li2SO4. Thus, it was decided to use only the ETH500/DCE phase in subsequent experiments. 
Table 10: Potential limits and windows of Ag| ETH500 (10 mM)/ DCE or NPOE|| as 
observed in aq. Li2SO4 (50 mM) and MgSO4 (50 mM). Potential: against Ag/AgCl and 
Ag/Ag2SO4 
Aq. Phase Organic phase 
Anodic  
Limit/  V 
Cathodic  
Limit/ V  
Window/ 
V 
Cdl-a/  
µF 
Cdl-c/  
µF 
Fig 
Li2SO4 (50 mM) 
ETH500 (10 mM)/ DCE 0.40 -0.45 0.85 17 -1.03 29 
ETH500 (10 mM)/ NPOE 0.45 -0.65 1.1 15 -9.78 33  
MgSO4 (50 mM) 
ETH500 (10 mM)/ DCE 0.4 -0.6 1 10.34 -13.96 41 
ETH500 (10 mM)/ NPOE 0.4 -0.6 1 16.54 1.73 42 
*ETH500 (10 mM)/ DCE 0.05 -0.9 0.95 58.97 43.21 43 
*In the figure below the Ag| ETH500 (10 mM)/ DCE observed in aq. MgSO4 (50 mM) 
Potential: against Ag/Ag2SO4  
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Fig 42: Replicate background of CVs of Ag|ETH500 (10 mM)/ DCE|| in aq. MgSO4 (50 mM) phases. 
Einitial = 0.05 V; Efinal = 0.05 V; Elow = -0.9 V; scan rate = 10 mV/ s 
5.2 Preliminary study with the ionophore Dibenzo-18-Crown-6 (DB18C6) 
K+ and NH4+ were used as test ions for the functioning of DB18C6-facilitated ion transfer 
across the membrane stabilized W| DCE interface assembly with custom made four electrode 
cell. The notation of the sensor employed hence forth would be: 
Ag|ETH500 (10 mM)/ DB18C6 (50 mM)/ DCE|| 
Fig 43 shows reproducible background CVs of Ag|ETH500 (10 mM)/ DB18C6 (50 mM)/ 
DCE|| in aq. MgSO4.The corresponding potential window was from 0.05 V to -0.65 V. By 
comparing this figure with Fig 42, one can see the narrowing of the potential window from 
1.0 V to 0.70 V because of DB18C6 in the organic phase. Fig 45 and 46 re-demonstrate the 
absence of ion-transfer peak for K+ and NH4+ ions at Ag|ETH500 (10 mM)/ DCE||.  Fig 46 
and 47 show this is no more the case for Ag|ETH500 (10 mM)/ DB18C6 (50 mM)/ DCE||. 
For this sensor, peaks which increased with three increasing test concentrations (0, 0.1, 0.2 
and 0.4 mM) were observed for both ions. This a demonstration of facilitated ion transfer in 
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action. Various CV peak characteristics have been compiled in Table 10 and 11 for each ion 
and each concentration. 
 
 
Fig 43: Replicate background CVs of Ag|ETH500 (10 mM)/ DB18C6 (50 mM)/ DCE|| in aq. MgSO4 
(50 mM). Einitial = Efinal = 0.05 V; Efinal = -0.65 V; scan rate = 10 mV/ s 
 
Fig 44: CVs of Ag|ETH500 (10 mM)/ DCE|| before (black) and with K+ (red = 0.1, green = 0.2, and 
blue = 0.4 mM) in aq. MgSO4 (50 mM). Einitial = Efinal = 0.05 V; Elow =- 0.9 V; scan rate = 10 mV/ s 
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Fig 45: CVs of Ag|ETH500 (10 mM)/ DCE|| before (black) and with NH4+ (0, 0.1, 0.2, 0.4 mM) in aq. 
MgSO4 (50 mM). Einitial = Efinal = 0.05 V; Elow = -0.9 V; scan rate = 10 mV/ s 
 
Fig 46: CVs of K+ (0, 0.1, 0.2, and 0.4 mM) at Ag|ETH500 (10 mM)/ DB18C6 (50 mM)/ DCE|| in aq. 
MgSO4 (50 mM). Einitial = Efinal = 0.05 V; Efinal = 0.65 V; scan rate = 10 mV/ s 
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Fig 47: CVs of NH4+ (0, 0.1, 0.2, and 0.4 mM) at Ag|ETH500 (10 mM)/ DB18C6 (50 mM)/ DCE|| in 
aq. MgSO4 (50 mM). Einitial = Efinal = 0.05 V; Efinal = 0.65 V; scan rate = 10 mV/ s 
According to Fig 47 and Fig 48, the transfer of K+ and NH4+ ions from the aq. MgSO4 phase 
to the ETH500/ DB18C6/ DCE phase is a facilitated ion transfer, and this has already been 
explained in the literature by equation (17) [79]: 
K+/ NH4+ (aq.) + DB18C6 (DCE)  [K+ / NH4+DB18C6] (DCE)   (17)                         
In addition, the revers reaction for would be:  
[K+/ NH4+DB18C6] (DCE)   K+ / NH4+ (aq.) + DB18C6 (DCE)      (18)            
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Table 11: Peak characteristics versus concentration for CVs of K+ at Ag|ETH500 (10 mM)/ DB18C6 (50 mM)/ DCE|| in MgSO4 (50 mM). 
Potentials are according to: )1(.,|| 2442 MSOAqSOAgAg
O
wOAg EEE −−∆−= ϕ  
Aq. K+ / mM 
Ep, W→O 
/ V 
 
Ep, O→W 
/ V 
i p W→O 
/ µA 
i p O→W 
/ µA 
ibg W→O 
/ µA   
i  bg O→W 
/ µA    
∆ i p W→O 
/ µA   
∆ i p O→W 
/ µA    
∆ Ep 
 
Eº´/ V 
0.1 -0.46 -0.38 -6.00 5.32 0 -0.499 -6.00 5.82 0.08 -0.42 
0.2 -0.46 -0.37 -14.4 11.6 0.759 -2.24 -15.2 13.8 0.09 -0.42 
0.4 -0.46 -0.37 -16.7 13.7 1.32 -2.20 -18.0 15.9 0.09 -0.42 
Table 12: Peak characteristics versus concentration for CVs of NH4+ at Ag|ETH500 (10 mM)/ DB18C6 (50 mM)/ DCE|| in MgSO4 (50 mM). 
Potentials are according to: )1(.,|| 2442 MSOAqSOAgAg
O
wOAg EEE −−∆−= ϕ  
Aq. NH4+ /  
mM 
Ep, W→O 
/ V 
Ep, O→W 
/ V 
i p W→O 
/ µA 
i p O→W 
/ µA 
i  bg W→O 
/ µA   
i  bg O→W 
/ µA    
 ∆ i p W→O 
/ µA   
 ∆ i p O→W 
/ µA    
 ∆ Ep 
 
Eº´/ V 
0.1 -0.48 -0.4 -0.73 1.72 0.28 0.46 -1.01 1.26 0.08 -0.43 
0.2 -0.48 -0.38 -0.13 2.33 0.23 0.15 -0.36 2.18 0.1 -0.43 
0.4 -0.49 -0.38 -2.74 3.46 0.19 -0.67 -2.93 4.13 0.11 -0.44 
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From this part of work we can conclude that  
a)DB18C6 make good complexation with K+ and NH4+. 
b) when we try to detect K+ and NH4+ ions without DB18C6  no peaks were bserved, but after 
adding DB18C6 in organic phase, the ion transfer from aqueous phase to organic phase and 
come back again.The disadvantages in presence of  DB18C6  the potential window was 
narrower in Fig 48. 
 
Fig 48: Potential windows of Ag|ETH500 (10 mM)/ DCE|| (red) and Ag|ETH500 (10 mM)/ 
DB18C6 (50 mM)/ DCE|| (black) in aq. MgSO4 (50 mM). Scan rate = 10 mV/ s. 
Fig 49 A and B respectively show the CVs of K+ and NH4+ at the Ag|ETH500(10 mM)/DCE|| 
and Ag|ETH500(10 mM)/ DB18C6(50 mM)/DCE|| sensors. Furthur more in Table (11) and 
(12) demonstrate the reproducibility of the CVs characteristics at three different 
concentrationd based on Figs 46 and 47. 
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Fig 49: (A) CVs of K+ (0.4 mM) at Ag|ETH500 (10 mM)/ DCE|| (red) and Ag|ETH500 (10 
mM)/ DB18C6 (50 mM)/ DCE|| (black) in aq. MgSO4 (50 mM). (B) As in A but for NH4+.  
5.3 Sensor operation optimization using Tenofovir 
After selecting the most suitable pair of hydrophobic and aqueous phases, in this section the 
response of the resulting sensors to tenofovir the in aq. phase (Aq. MgSO4) at different 
concentrations was tested preliminarily as shown in Fig 50. The tenofovir cations transfer 
from the aq. MgSO4 phase to the ETH500/DCE phase was exhibited differently from that of 
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the K+ and NH4+ ions (Fig 51). Its CV characteristics at three concentrations are summarized 
in Table 13. 
 
Fig 50: CVs of tenofovir (0, 0.1, 0.2, and 0.4 mM) at Ag|ETH500 (10 mM)/ DCE|| in aq. MgSO4 (100 
mM). Einitial = Efinal = 0.05 V; Efinal = -0.9 V; scan rate = 10 mV/ s 
 
 
 
 
73 
 
Table 13: Peak characteristics versus concentration for CVs of tenofovir at Ag|ETH500 (10 mM)/ DB18C6 (50 mM)/ DCE|| in MgSO4 (50 
mM). Potentials are according to: )1(.,|| 2442 MSOAqSOAgAg
O
wOAg EEE −−∆−= ϕ  
Tenofovir/  
mM 
Ep, W→O 
/ V 
Ep, O→W 
/ V 
ip W→O 
/ µA 
ip O→W 
/ µA 
ibg W→O 
/ µA   
ibg O→W 
/ µA    
 ∆ ip W→O 
/ µA   
 ∆ ip O→W 
/ µA    
 ∆Ep 
 
Eº´/ V 
0.1 -0.64 -0.57 -0.05 0.74 0.28 0.65 -0.33 0.09 0.07 -0.61 
0.2 -0.60 -0.51 -0.38 1.01 0.31 0.64 -0.69 0.37 0.09 -0.56 
0.4 -0.60 -0.48 -0.74 1.23 0.31 0.59 -1.05 0.64 0.12 -0.54 
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Fig 51: CV responses of Ag|ETH500 (10 mM)/DCE|| to 0.4 mM K+ (red), NH4+ (green), and 
tenofovir (blue) in aq. MgSO4 (100 mM). Black curve = 0 mM. E initial = E final = -0.05; E low = -0.9 V; 
scan rate = 10 mV/ s. 
When the DB18C6 (50 mM) was added to ETH500 in DCE, the resulting sensor’s 
configuration will be as follows: Ag|ETH500 (10 mM)/DB18C6(50 mM)/DCE|| as shown in 
fig (52), moreover when the K+ and NH4+ ions were added it is observed that the K+ ion has 
higher response than TNVR according to the literature the DB18C6 has strong complexion 
abilities and has high affinity for alkali metal cations [80] as shown in fig (53) 
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Fig 52: CV responses of Ag|ETH500 (10 mM)/DB18C6 (50 mM)/DCE|| to 0.4 mM K+ (red), NH4+ 
(green), and tenofovir (blue) in aq. MgSO4 (100 mM). Black curve = 0 mM. E initial = E final = 0.05 V; E 
low = -0.65 V; scan rate = 10 mV/ s 
 
Fig 53: CV responses of Ag|ETH500 (10 mM)/ DB18C6/DCE|| to 0.4 mM K+ (blue), NH4+ (red), and 
tenofovir (green) in aq. MgSO4 (100 mM). Black curve = 0 mM E initial = E final = -0.05; E low = -
0.65 V; scan rate = 10 mV/ s.
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Table 14: Peak characteristics versus concentration for CVs of tenofovir at Ag|ETH500 (10 mM)/ DB18C6 (50 mM)/ DB18C6 (50 mM)/DCE|| 
in MgSO4 (50 mM). Potentials are according to: )1(.,|| 2442 MSOAqSOAgAg
O
wOAg EEE −−∆−= ϕ  
Tenofovir/  
mM 
Ep, W→O/  
V 
Ep, O→W/  
V 
ip W→O/  
µA 
ip O→W/  
µA 
ibg W→O/  
µA   
i bg O→W/  
µA    
 ∆ip W→O/  
µA   
 ∆ip O→W/  
µA    
 ∆ Ep/  
V 
Eº´/  
V 
0.1 -0.49 -0.41 -0.90 1.60 0.202 0.93 -1.10 0.67 0.08 -0.45 
0.2 -0.47 -0.39 -1.57 2.05 0.196 1.09 -1.77 0.96 0.08 -0.43 
0.4 -0.47 -0.38 -2.28 2.52 0.234 1.06 -2.51 1.46 0.09 -0.43 
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5.3.1 Cyclic voltammetry at different scan rate 
The purpose of this section is to choose the best scan rate by using one concentration of 
tenofovir (0.2 mM) for the two sensors as shown in Fig 54 and Fig 55 respectively.  
 
Fig 54: CV of tenofovir (0.4 mM) at various scan rates at the Ag|ETH500 (10 mM)/DCE|| sensor in 
aq. Li2SO4 (100 mM). Scan rates: 2 to 100 mV/ s. 
 
Fig 55 : CV of tenofovir (0.4 mM) at various scan rates at the Ag|ETH500 (10 mM)/ DB18C6 (50 
mM)/ DCE|| sensor in aq. MgSO4 (100 mM). Scan rates: 2 to 100 mV/ s. 
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In order to select an appropriate scan rate with the best signal-to-noise ratio (S/N) for use in 
further studies, peak height to background current ratios were plotted against scan rate for 
both sensors between 2 and 100 mV/s (see Figure 56). The W O ion transfer peak signal of 
the sensor without DB18C6 exhibited an S/N ratio that increased significantly with 
decreasing scan rate up to a  maximum of S/N = 16 at 5 mV/s. The equivalent of this was not 
observed for the reverse OW peak, the S/N ratio which remained practically independent of 
scan rate but with an indication of a slightly broad maxima at about 25 mV/s. The W O  
and O  W peaks of the sensor with DB18C6 also behaved similarly as the respective 
corresponding peaks of the first sensor. However, this time, the W O peaks S/N ratio 
dependence on scan rate was only slight and increased only up to S/N of 2 at 2 mV/s. Based 
on consideration of a reasonable S/N ratio but faster sample through put rate of the current 
CV operation mode, the scan rate of 25 mV/s was chosen for both sensors and used in further 
experiments.  
 
Fig 56: Peak current to background current (S/N) ratio versus scan rate for Ag|ETH500 (10 
mM)/DCE|| (▲ and ▼) and Ag|ETH500 (10 mM)/ DB18C6 (50 mM)/ DCE|| (■ and ●) at 0.4 mM 
2tenofovir in aq. MgSO4 (100 mM).  
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It is very important to know whether the reaction is reversible, irreversible or quasi-
reversible. If ∆Ep is greater than 200/n mV, it is reversible; if ∆Ep is approximately 60/n mV, it 
is irreversible, but if ∆Ep is between 60/n mV and 200/n mV it is quasi-reversible. But in this 
case it was reversible. 
The observation from Fig 59 combined with Table (16) and (17), the Eº is constant – i.e. 
independent from the scan rate or log of scan rate. 
 
Fig 57: Peak potentials (Ep) versus log scan rate for tenofovir (0.4 mM) at Ag|ETH500 (10 
mM)/DCE|| (▲ & ▼) and Ag|ETH500 (10 mM)/ DB18C6 (50 mM)/ DCE|| (■ & ●) in aq. MgSO4 
(100 mM) 
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Fig 58: Peak separation (∆Ep) versus log scan rate for 0.4 mM tenofovir at Ag|ETH500 (10 
mM)/DCE|| (■) and Ag|ETH500 (10 mM)/ DB18C6 (50 mM)/ DCE|| (●) in aq. MgSO4 (100 mM) 
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Table 15: Linear fitting parameters obtained from peak potential (Ep) versus scan rate plots, and formal potentials of simple and facilitated-ion 
transfer for tenofovir (0.4 mM) in aq. Li2SO4 (100 mM). Potentials are according to: )1(.,|| 2442 MSOAqSOAgAg
O
wOAg EEE −−∆−= ϕ  
Sensor Configuration Signal Scan rate/ 
mV/s 
R  
 
N E°±SD 
/V 
Intercept/ 
V 
Slope /  
V 
Sensor 1 Ag|ETH500 (10 mM)/DCE|| ip, W→O 10 – 100 -0.9732 6 -0.48 ± 0.007 -0.482 -0.04 ± 0.004 
ip, O→W 2 – 75 0.9691 7 -0.48 ± 0.003 -0.453 0.02 ± 0.002 
Sensor 2 Ag|ETH500 (10 mM)/ DB18C6 (50 mM)/ DCE|| ip, W→O 2 – 100 -0.9799 8 -0.38 ± 0.003 -0.402 -0.04 ± 0.004 
ip, O→W 2 – 100 0.9876 8 -0.38 ± 0.003 -0.370 0.05 ± 0.003 
Table 16: Parameters obtained by averaging or from linear plots of the W O and O  W ion-transfer peak potentials (Ep) versus log scan rate 
for tenofovir (0.4 mM) in aq. Li2SO4 (100 mM). Potentials: )1(.,|| 2442 MSOAqSOAgAg
O
wOAg EEE −−∆−= ϕ  
Sensor  Configuration Scan rate/ mV/s R (N = 4) E°±SD/ V Intercept/ V Slope / V 
Sensor 1 Ag|ETH500 (10 mM)/DCE|| 2 – 15 0.9964 -0.48 ± 0.003 0.047 0.04 ± 0.003 
Sensor 2 Ag|ETH500 (10 mM)/ DB18C6 (50 mM)/ DCE|| 25 – 100 0.9902 -0.38 ± 0.003 0.005 0.11 ± 0.01 
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Fig 59: Formal potentials (E°′) obtained at different scan rates with Ag|ETH500 (10 mM)/DCE|| (■) 
and Ag|ETH500 (10 mM)/DB18C6 (50 mM)/DCE|| (●) for tenofovir (0.4 mM) in aq. MgSO4 (100 
mM) 
In order to estimate the value of diffusion coefficient, ∆ip was plotted versus square root of 
scan rate and scan rate in Fig (61) and Fig (62). According to equation (18), the value of 
diffusion coefficient was evaluated from the slope values in Table (15) and (16) as shown in 
two table below the values of W O not O  W because the R values were better than O  
W in both sensor. 
∆ip = 0.4463nFA[nF/RT]1/2 Cbulk D1/2 ν1/2       (19) 
Where ip is peak current; F is Faraday constant (96485 C/ mol); D is diffusion coefficient 
(cm2/ s) of the electroactive species; A is the area of the electrode/cm2; ν is the sweep rate (V/ 
s); R is the universal gas constant (8.413 J/mol K) and T is temperature (298 K) and Cbulk 
concentration (mol cm-3) of the analyte solution. The value found for D (see Table 17 and 18) 
were very smal, indicating that diffusion through the membrane was rate limiting process. 
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Fig 60: Peak current (∆ip) versus square root of scan rate plots for tenofovir (0.4 mM) transfer at 
Ag|ETH500 (10 mM)/DCE|| (■ & ■) and Ag|ETH500 (10 mM)/ DB18C6 (50 mM)/ DCE|| (■ & ■) in 
aq. MgSO4 (100 mM) 
 
Fig 61: Peak current (∆ip) versus scan rate plots for tenofovir (0.4 mM) at Ag|ETH500 (10 
mM)/DCE|| (■ & ■) and Ag|ETH500 (10 mM)/ DB18C6 (50 mM)/ DCE|| (■ & ■) in aq. MgSO4 (100 
mM)
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Table 17: Data obtained by linear-regression of plot of W O and O  W ion-transfer peak currents (∆ip) versus scan rate for in tenofovir (0.4 
mM)/ aq. Li2SO4 (100 mM) with indicated sensors 
Sensor  Configuration Scan rate/  
mV/s 
Signal R(N=5) Intercept/  
µA 
Slope/  
nA/mVs-1 
D/ 
cm2s-1 
Sensor 1 Ag|ETH500 (10 mM)/DCE|| 10 – 75 ip, W→O -0.9922 -0.548 -10.73 ± 0.7 2.48×10-11 
Sensor 2 Ag|ETH500 (10 mM)/ DB18C6 (50 mM)/ DCE|| 15 – 100 ip, W→O -0.9974 -0.699 -107.3 ± 0.4 9.936×10-9 
Table 18: Data obtained by linear-regression of plot of W O and O  W ion-transfer peak currents (∆ip) versus square root of scan rate for in 
tenofovir (0.4 mM)/ aq. Li2SO4 (100 mM) with indicated sensors 
Sensor  Configuration Scan rate/  
mV/s 
Signal R (N=5) Intercept/  
µA 
Slope /  
nA/mVs-1 
D/  
cm2s-1 
Sensor 1 Ag|ETH500 (10 mM)/DCE|| 10 – 75 ip, W→O -0.9995  -0.209 -128.7±2.3 3.573×10-9 
Sensor 2 Ag|ETH500 (10 mM)/ DB18C6 (50 mM)/ DCE|| 15 -100 ip, W→O -0.9979 -0.235 -149.2 ± 5.5 4.803×10-9 
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Table 19: CV parameters obtained at various scan rates for tenofovir (0.4 mM) with the Ag|ETH500 (10 mM)/DCE|| sensor in aq. Li2SO4 (100 
mM). ip = the total peak current before background substraction; i bg = backckground current at the peak potential; ∆ ip = ip - ibg; Potentials: 
)1(.,|| 2442 MSOAqSOAgAg
O
wOAg EEE −−∆−= ϕ  
ν/ 
/ mV s-1 
log (ν 
 / mV s-1)  
ν 
½ 
/ (mV s-1) 
Ep, W→O 
/ V 
Ep, O→W 
/ V 
ip W→O 
/ µA 
 ip O→W 
/ µA 
ibg W→O 
/ µA   
ibg O→W 
/ µA    
∆ip W→O 
/ µA   
∆ ip O→W 
/ µA    
S/N 
W→O 
S/N 
O→W 
ip W→O  
/i p O→W 
E° 
/V 
∆Ep/ 
/V 
100 2 10 -0.56 -0.43 -2.05 1.40 -0.923 0.907 -1.13 0.493 1.22 0.54 -1.46 -0.50 0.13 
75 1.875 8.660 -0.55 -0.42 -1.97 1.42 -0.642 0.771 -1.33 0.649 2.07 0.84 -1.39 -0.49 0.13 
50 1.699 7.071 -0.55 -0.42 -1.56 1.18 -0.453 0.612 -1.11 0.568 2.44 0.93 -1.32 -0.49 0.13 
25 1.398 5 -0.53 -0.43 -1.09 0.891 -0.225 0.446 -0.865 0.445 3.84 1.00 -1.22 -0.48 0.1 
15 1.176 3.873 -0.53 -0.43 -0.835 0.713 -0.129 0.364 -0.706 0.349 5.47 0.96 -1.17 -0.48 0.1 
10 1 3.162 -0.52 -0.43 -0.696 0.621 -0.084 0.294 -0.612 0.327 7.31 1.11 -1.12 -0.48 0.09 
5 0.699 2.236 -0.52 -0.44 -0.438 0.405 -0.026 0.209 -0.412 0.196 15.65 0.94 -1.08 -0.48 0.08 
2 0.301 1.414 -0.51 -0.45 -0.226 0.253 0.020 0.143 -0.246 0.110 12.19 0.77 -0.89 -0.48 0.06 
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Table 20: CV parameters obtained at various scan rates for tenofovir (0.4 mM) with the Ag|ETH500 (10 mM)/ DB18C6 (50 mM)/DCE|| sensor 
in aq. Li2SO4 (100 mM). ip = the total peak current before background substraction; i bg = backckground current at the peak potential; ∆ ip = ip - 
ibg; Potentials:: )1(.,|| 2442 MSOAqSOAgAg
O
wOAg EEE −−∆−= ϕ   
ν 
/ mV s-1 
log (ν 
/ mV s-1) 
ν 
½ 
/ (mV s-1) 
Ep, W→O 
/V 
Ep, O→W 
/V 
i p W→O 
/ µA 
 i p O→W 
/ µA 
i  bg W→O 
/ µA   
i  bg O→W 
/ µA    
∆ i p W→O 
/ µA   
∆ i p O→W 
/ µA    
S/N 
W→O 
S/N 
O→W 
∆ Ep 
/ V 
i p W→O  
/i p O→W 
E° 
/V 
100 2 10 -0.49 -0.27 -3.62 2.61 -1.87 1.18 -1.75 1.43 0.936 1.212 0.22 1.39 -0.38 
75 1.875 8.660 -0.48 -0.28 -3.04 2.21 -1.53 1.10 -1.51 1.11 0.987 1.009 0.2 1.38 -0.38 
50 1.699 7.071 -0.48 -0.29 -2.52 1.91 -1.24 0.939 -1.28 0.971 1.040 1.034 0.19 1.32 -0.39 
25 1.398 5 -0.46 -0.31 -1.77 1.49 -0.813 0.654 -0.957 0.836 1.177 1.278 0.15 1.30 -0.39 
15 1.176 3.872 -0.46 -0.31 -1.43 1.28 -0.589 0.592 -0.841 0.688 1.428 1.162 0.15 1.18 -0.39 
10 1 3.162 -0.44 -0.32 -1.14 1.06 -0.484 0.534 -0.656 0.526 1.355 0.985 0.12 1.47 -0.38 
5 0.699 2.236 -0.44 -0.33 -0.788 0.768 -0.314 0.392 -0.474 0.376 1.510 0.959 0.11 1.07 -0.39 
2 0.301 1.414  -0.41 -0.36 -0.429 0.407 -0.158 0.231 -0.271 0.176 1.715 0.762 0.05 1.03 -0.39 
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5.3.2 Sensor Stability 
Furthermore, the stability of the sensor was checked by recording CVs at intervals for three 
hours before and after saturation (washing) of the organic phase with water. Figures 62 and 
63 are overlays of typical results for  that of the water-washed (saturated) organic phase. Fig 
64 and Fig 65 shows how long the sensor will be stable, where peak heights are plotted 
against time for both sensors (without and with DB18C6).  
In order to evaluate the stability of the sensor, the time against peak current were ploted for 
both sensors between (zero-180 min) fig( 64) and fig (65) shows how the sensor was stable 
without DB18C6 for 90 second (from 30-120 min)  W O  
 
Fig 62: Time-lapse simple-ion transfer CV of tenofovir (0.2 mM) at the Ag|ETH500 (10 mM)/ 
DB18C6 (50 mM)//DCE|| sensor in aq. MgSO4 (100 mM). Scan rate: 25 mV/ s 
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Fig 63: Time-lapse simple-ion transfer CV of tenofovir (0.2 mM) at the Ag|ETH500 (10 mM)/ DCE|| 
sensor in aq. MgSO4 (100 mM). Scan rate: 25 mV/ s 
 
Fig 64: Peak current (∆ip) versus time for tenofovir (0.2 mM) at the Ag|ETH500 (10 mM)/ DCE|| in 
aq. MgSO4 (100 mM). Curves: before (▲ & ▼) and after (■ & ●) overnight equilibration with DI 
water. Scan rate: 25 mV/ s  
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Fig 65: Peak current (∆ip) versus time for tenofovir (0.2 mM) at the Ag|ETH500 (10 mM)/ DCE|| in 
aq. MgSO4 (100 mM). Curves: before (▲ & ▼) and after (■ & ●) overnight equilibration with DI 
water. Scan rate: 25 mV/ s 
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Table 21: Operational stability statistics on peak currents (∆ip) of tenofovir (0.2 mM) at the Ag|ETH500 (10 mM)/ DCE|| and Ag|ETH500 (10 
mM)/ DB18C6 (50 mM)/DCE|| sensors in aq. MgSO4 (100 mM). Scan rate: 25 mV/ s 
    0 – 180 min 10 – 180 min 10 – 100 min 
Sensor Configuration CV  
signal  
Before/ After 
DI water wash 
Mean ± SD 
/ µA (N=14) %SD 
Mean ±SD/ µA  
(N= 6 or *4) 
%SD Mean ±SD/ µA 
(N = 7) 
%SD 
Sensor 2 
 
Ag|ETH500(10 mM)/ DB18C6(50 mM)/DCE|| ∆ip, W→O Before washing -2.80± 0.5 -18.44 -2.85±0.5 -17.75 -2.62±0.20 -6.78 
After washing -2.38±0.6 -25.48 2.96±0.6 20.67 -2.31±0.14 -6.17 
∆ip O→W Before  washing 2.39±0.2 10.38 -2.93±0.5 -18.43 2.48±0.21 8.55 
After washing 2.18±0.7 31.40 2.53±0.2 11.52 2.17±0.45 15.92 
Sensor 1 
 
Ag|ETH500 (10 mM)/ DCE|| ∆ip, W→O Before washing -1.34±0.2 -18.40 -1.74±0.2 -12.09 -1.30±0.08 -6.13 
After washing 1.26±0.3 20.35 1.71±0.3 17.90 -1.70±0.19 -11.27 
∆ip, O→W Before washing -1.67±0.2 -13.21 -1.56±0.2* -14.62 1.22±0.090 7.75 
After washing 1.54±0.3 22.72 1.35±0.2 17.94 1.60±0.3 17.28 
The started time for sensor 2 before and after wash was same (45 min), but the ending was ranging between (180 – 120) min.
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Fig 66 shows plots of ip (peak current) versus concentration for the two sensors under study at 
different concentrations of tenofovir from 0.1 µM to 200 µM. The various analytical 
parameters extracted from these curves have been compiled in Table (22). The detection limit 
varied from sensor to other as seen in table. The minus signs just show the signals are 
cathodic, while there is no much difference in sensitivity and the intercept was calculated to 
determine the background noise. In addition to the R value, detection limit and linearity rang 
were determined. The working potentials shown are average peak potentials for the sensors 
with water-saturated organic phase. Indeed, it would be the sensor Ag|ETH500/DCE||  that 
will provide more selective tenofovir detection instead of the sensor Ag|ETH500 (10 
mM)/DB18C6(50 mM)/DCE|| because the latter would also respond to K+, NH4+, and similar 
ions resulting in positive errors. 
 
Fig 66: peak current (∆ip) versus concentration of tenofovir at Ag|ETH500 (10 mM)/ DCE|| (■ & ●) 
and Ag|ETH500 (10 mM)/ DB18C6 (50 mM)/DCE|| (▲ &▼) sensors in aq. MgSO4 (100 mM). Scan 
rate: 25 mV/ s. 
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Table 22: Analytical figures of merit of Ag|ETH500 (10 mM)/ DCE|| (■ & ●) and Ag|ETH500 (10 mM)/ DB18C6 (50 mM)/DCE|| sensors for 
the the amperometric detection of tenofovir in aq. MgSO4 (100 mM). Scan rate: 25 mV/ s. Potentials: 
errorEEE OwMSOAqSOAgAg
O
wOAg +∆=−∆+= − ϕϕ )1(.,|| 2442  
Sensors  Working 
potential/ V 
Signal R, 
N = 5 
Intercept/ 
µA 
Sensitivity /  
nA µM-1 
DOL 
/µM 
Linearity 
Range/ µM 
Sensor (1) Ag|ETH500 (10 mM)/ DCE|| -0.52± 0.05 ip, W→O -0.9965 -0.509 -7.09 ± 0.3 5 15 –  100 
-0.33± 0.02 ip, O→W 0.9922 0.548 3.05 ± 0.2 18 60 – 200 
Sensor (2) Ag|ETH500 (10 mM)/ DB18C6 (50 mM)/DCE|| -0.47±0.02 ip, W→O -0.9984 -0.823 -6.32 ± 0.2 2.9 9 – 200 
-0.31± 0.01 ip, O→W 0.9986 0.694 4.52 ± 0.1 3 9 – 100 
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CHAPTER VI: SUMMARY AND FUTURE WORKS 
6.1 Summary 
This thesis has found that both simple and facilitated ion transfer is possible for tenofovir at 
the membrane stabilized Water/ dichloroethane interface. The later was demonstrated by 
using the solution of DB18C6 in dichloroethane. The outcomes could contribute to the goals 
of this work such as meeting the demand for quick, economical, portable, and personalized 
devices.  
Both the simple ion-transfer sensor (Ag|ETH500 (10 mM) /DCE|) and facilitated ion-transfer 
sensor (Ag|ETH500 (10 mM)/ DB18C6 (50 mM)/DCE||) exhibited operational stability of 90 
min. 25 mV/ s was found to be an optimal scan rate for CV interrogation of the sensors after 
consideration of reasonable S/N ratio and sample throughput rates. Furthermore the diffusion 
coefficient of the analyte was estimated as 2.48 × 10-11 and 9.936×10-9 cm2/s for sensor (1) 
and (2) respectively. These estimates may be taken to be the diffusion coefficient of tenofovir 
in the hydrophilic membrane separating the organic phase from the aqueous phase. For both 
of the Ag|ETH500 (10 mM)/ DCE|| (1) and Ag|ETH500 (10 mM)/ DB18C6 (50 mM)/DCE|| 
(2) sensors, the WO ion-transfer peaks provided superior signal quality over the 
corresponding reverse peaks. According to the calibration curve based on the forward peak, a 
detection limit of about 5 µM, a linear range of 15 – 100 µM, and sensitivity of 7.09 nA µM-1 
towards tenofovir were found. For the reverse peak, these were respectively 3 µM, 6.32 nA 
µM-1, and 9 – 100 µM. In this way, a four-electrode-based amperometric detection of 
tenofovir at a membrane-stabilized liquid | liquid interface, both under simple and ionophore-
facilitated mode, has been demonstrated as promising for analysis of this analyte as a 
representative of the nucleotide/ nucleoside reverse transcriptase inhibitor ARV drugs. 
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6.2 Future work or recommendations 
(i) Test other sensor pre-conditioning and conditioning techniques as well as signal 
interrogation techniques to improve the sensors’ analytical characteristics 
(ii) Testing if other ionophores would give better sensors  
(iii) Interference studies 
(iv) Synthetic real sample applications can be compared with standard methods in a single 
blind experiment. 
(v) Exploring ways of improving analytical performance via membrane-impregnated 
selectivity and sensitivity enhancing agents 
(vi) Testing the sensor for its response to other nucleotide/ nucleoside reverse transcriptase 
inhibitor ARV drugs  
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